JP2018510857A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510857A5 JP2018510857A5 JP2017546173A JP2017546173A JP2018510857A5 JP 2018510857 A5 JP2018510857 A5 JP 2018510857A5 JP 2017546173 A JP2017546173 A JP 2017546173A JP 2017546173 A JP2017546173 A JP 2017546173A JP 2018510857 A5 JP2018510857 A5 JP 2018510857A5
- Authority
- JP
- Japan
- Prior art keywords
- imidazol
- alkyl
- fluorophenyl
- imidazo
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 153
- 125000000217 alkyl group Chemical group 0.000 claims 118
- 229910052736 halogen Inorganic materials 0.000 claims 103
- 150000002367 halogens Chemical class 0.000 claims 103
- 125000004093 cyano group Chemical group *C#N 0.000 claims 99
- 229910052739 hydrogen Inorganic materials 0.000 claims 78
- 239000001257 hydrogen Substances 0.000 claims 78
- 125000001188 haloalkyl group Chemical group 0.000 claims 63
- 150000002431 hydrogen Chemical class 0.000 claims 59
- -1 imidazolidin-2-onyl Chemical group 0.000 claims 52
- 150000001875 compounds Chemical class 0.000 claims 47
- 229940124597 therapeutic agent Drugs 0.000 claims 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 19
- 125000003545 alkoxy group Chemical group 0.000 claims 19
- 239000003814 drug Substances 0.000 claims 19
- 201000010099 disease Diseases 0.000 claims 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 16
- 239000012453 solvate Substances 0.000 claims 16
- 239000003112 inhibitor Substances 0.000 claims 14
- 125000002619 bicyclic group Chemical group 0.000 claims 13
- 229940002612 prodrug Drugs 0.000 claims 13
- 239000000651 prodrug Substances 0.000 claims 13
- 150000001204 N-oxides Chemical class 0.000 claims 12
- 206010028980 Neoplasm Diseases 0.000 claims 12
- 229910052757 nitrogen Inorganic materials 0.000 claims 11
- 229910052760 oxygen Inorganic materials 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- ULZZPSONFYHMKY-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=CN(C=1C1=CC=C2C=NNC2=C1)C)C ULZZPSONFYHMKY-UHFFFAOYSA-N 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 239000002246 antineoplastic agent Substances 0.000 claims 7
- 125000004429 atom Chemical group 0.000 claims 7
- 208000024891 symptom Diseases 0.000 claims 7
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 6
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 6
- 229940127089 cytotoxic agent Drugs 0.000 claims 6
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 6
- 229960005277 gemcitabine Drugs 0.000 claims 6
- 229960001756 oxaliplatin Drugs 0.000 claims 6
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 6
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims 4
- NTQODZHOLXYINM-UHFFFAOYSA-N 5-[4-(3-chlorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1 NTQODZHOLXYINM-UHFFFAOYSA-N 0.000 claims 4
- CJNVIIQOYLDXLF-UHFFFAOYSA-N 5-[4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1)C CJNVIIQOYLDXLF-UHFFFAOYSA-N 0.000 claims 4
- AEMRATBUIXJFLD-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-1H-imidazol-5-yl]-1-methylbenzimidazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CNC=1C=1C=CC2=C(N(C=N2)C)C=1 AEMRATBUIXJFLD-UHFFFAOYSA-N 0.000 claims 4
- BFIPITLAVPWQPQ-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CNC=1C1=CC=C2C=NNC2=C1 BFIPITLAVPWQPQ-UHFFFAOYSA-N 0.000 claims 4
- ICBOPMCVTUHGHV-UHFFFAOYSA-N 6-[4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=CNC=1C1=CC=C2C=NNC2=C1)C ICBOPMCVTUHGHV-UHFFFAOYSA-N 0.000 claims 4
- 239000012664 BCL-2-inhibitor Substances 0.000 claims 4
- 229940123711 Bcl2 inhibitor Drugs 0.000 claims 4
- 206010009944 Colon cancer Diseases 0.000 claims 4
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 4
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 claims 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims 4
- 208000035269 cancer or benign tumor Diseases 0.000 claims 4
- 239000012830 cancer therapeutic Substances 0.000 claims 4
- 210000001072 colon Anatomy 0.000 claims 4
- 208000017169 kidney disease Diseases 0.000 claims 4
- 208000032839 leukemia Diseases 0.000 claims 4
- 230000001404 mediated effect Effects 0.000 claims 4
- 229960001924 melphalan Drugs 0.000 claims 4
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims 4
- 208000011580 syndromic disease Diseases 0.000 claims 4
- RPDOYLXGZVEPIP-UHFFFAOYSA-N 5-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]-1H-indazole Chemical compound CN1C=NC(=C1C=1C=C2C=NNC2=CC=1)C=1C=C(C=CC=1)C RPDOYLXGZVEPIP-UHFFFAOYSA-N 0.000 claims 3
- NTTUJGGLUCSPCH-UHFFFAOYSA-N 5-[4-(3,4-difluorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CNC=1C=1C=C2C=NNC2=CC=1 NTTUJGGLUCSPCH-UHFFFAOYSA-N 0.000 claims 3
- DLEZDTFBZFAKFN-UHFFFAOYSA-N 5-[4-(3-fluorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1 DLEZDTFBZFAKFN-UHFFFAOYSA-N 0.000 claims 3
- HVLQWAFKHOUABL-UHFFFAOYSA-N 5-[4-(3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C1(=CC(=CC=C1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1)C HVLQWAFKHOUABL-UHFFFAOYSA-N 0.000 claims 3
- SZNIJWCNFIVOBU-UHFFFAOYSA-N 5-[5-(3-chlorophenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CN(C=1C=1C=C2C=NNC2=CC=1)C SZNIJWCNFIVOBU-UHFFFAOYSA-N 0.000 claims 3
- RIHHVSWLZUEDHV-UHFFFAOYSA-N 5-[5-(4-fluorophenyl)-1H-imidazol-4-yl]-1H-indazole Chemical compound FC1=CC=C(C=C1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1 RIHHVSWLZUEDHV-UHFFFAOYSA-N 0.000 claims 3
- GPKMHNBZFLYQJK-UHFFFAOYSA-N 6-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]-1H-indazole Chemical compound CN1C=NC(=C1C1=CC=C2C=NNC2=C1)C=1C=C(C=CC=1)C GPKMHNBZFLYQJK-UHFFFAOYSA-N 0.000 claims 3
- LJBLSXZRCXOCHC-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CNC=1C1=CC2=C(N=CS2)C=C1 LJBLSXZRCXOCHC-UHFFFAOYSA-N 0.000 claims 3
- SCIUZYVNHFPRJI-UHFFFAOYSA-N 6-[4-(3-fluorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1)C=1N=CNC=1C1=CC=C2C=NNC2=C1 SCIUZYVNHFPRJI-UHFFFAOYSA-N 0.000 claims 3
- ANNXUBINVQMBAZ-UHFFFAOYSA-N 6-[4-(3-methylphenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound C1(=CC(=CC=C1)C=1N=CNC=1C1=CC2=C(N=CS2)C=C1)C ANNXUBINVQMBAZ-UHFFFAOYSA-N 0.000 claims 3
- UBKVNNSPRLRNPY-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CN(C=1C1=CC=C2C=NNC2=C1)C UBKVNNSPRLRNPY-UHFFFAOYSA-N 0.000 claims 3
- FHZOCUSENXHZON-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-1H-imidazol-4-yl]-1H-indazole Chemical compound FC1=CC=C(C=C1)C=1N=CNC=1C1=CC=C2C=NNC2=C1 FHZOCUSENXHZON-UHFFFAOYSA-N 0.000 claims 3
- 210000000481 breast Anatomy 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 claims 2
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 claims 2
- PHKIAIZZFBUIRE-UHFFFAOYSA-N 1-methyl-6-[4-(3-methylphenyl)-1H-imidazol-5-yl]benzimidazole Chemical compound CN1C=NC2=C1C=C(C=C2)C1=C(N=CN1)C=1C=C(C=CC=1)C PHKIAIZZFBUIRE-UHFFFAOYSA-N 0.000 claims 2
- UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 claims 2
- CTRPRMNBTVRDFH-UHFFFAOYSA-N 2-n-methyl-1,3,5-triazine-2,4,6-triamine Chemical compound CNC1=NC(N)=NC(N)=N1 CTRPRMNBTVRDFH-UHFFFAOYSA-N 0.000 claims 2
- XXJWYDDUDKYVKI-UHFFFAOYSA-N 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline Chemical compound COC1=CC2=C(OC=3C(=C4C=C(C)NC4=CC=3)F)N=CN=C2C=C1OCCCN1CCCC1 XXJWYDDUDKYVKI-UHFFFAOYSA-N 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- OYODQTXFAIKAII-UHFFFAOYSA-N 5-(5-phenyl-1H-imidazol-4-yl)-1H-indazole Chemical compound C1(=CC=CC=C1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1 OYODQTXFAIKAII-UHFFFAOYSA-N 0.000 claims 2
- ZVPSOOCJOXYISK-UHFFFAOYSA-N 5-[4-(4-fluoro-3-methylphenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)C)C ZVPSOOCJOXYISK-UHFFFAOYSA-N 0.000 claims 2
- QDHWFEJWFFNZDX-UHFFFAOYSA-N 5-[5-(3,4-difluorophenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=C2C=NNC2=CC=1)C QDHWFEJWFFNZDX-UHFFFAOYSA-N 0.000 claims 2
- NRJVILXDKAQDGZ-UHFFFAOYSA-N 5-[5-(4-chlorophenyl)-1H-imidazol-4-yl]-1H-indazole Chemical compound ClC1=CC=C(C=C1)C=1N=CNC=1C=1C=C2C=NNC2=CC=1 NRJVILXDKAQDGZ-UHFFFAOYSA-N 0.000 claims 2
- OZVYHRCDWPPHQS-UHFFFAOYSA-N 6-(5-phenyl-1H-imidazol-4-yl)-1H-indazole Chemical compound C1(=CC=CC=C1)C=1N=CNC=1C1=CC=C2C=NNC2=C1 OZVYHRCDWPPHQS-UHFFFAOYSA-N 0.000 claims 2
- WYWHKKSPHMUBEB-UHFFFAOYSA-N 6-Mercaptoguanine Natural products N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 claims 2
- KMKLRSWSFMASCQ-UHFFFAOYSA-N 6-[2-ethyl-5-(4-fluoro-3-methylphenyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C=1C=CC=2N(C=1)N=CN=2 KMKLRSWSFMASCQ-UHFFFAOYSA-N 0.000 claims 2
- CUCLVNIPNJPRPH-UHFFFAOYSA-N 6-[2-methyl-5-(2,4,5-trifluorophenyl)-1H-imidazol-4-yl]-1,3-benzothiazole Chemical compound CC=1NC(=C(N=1)C1=C(C=C(C(=C1)F)F)F)C1=CC2=C(N=CS2)C=C1 CUCLVNIPNJPRPH-UHFFFAOYSA-N 0.000 claims 2
- VMQYBYYGVIXWET-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CNC=1C1=CC2=C(N=CS2)C=C1 VMQYBYYGVIXWET-UHFFFAOYSA-N 0.000 claims 2
- BZZGSVNUGLYXMO-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-1H-imidazol-5-yl]-1-methylbenzimidazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CNC=1C=1C=CC2=C(N(C=N2)C)C=1 BZZGSVNUGLYXMO-UHFFFAOYSA-N 0.000 claims 2
- BZVUIERTZMSASW-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CNC=1C1=CC=C2C=NNC2=C1 BZVUIERTZMSASW-UHFFFAOYSA-N 0.000 claims 2
- ZEBJYUXUNILVGE-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-2-ethyl-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)CC ZEBJYUXUNILVGE-UHFFFAOYSA-N 0.000 claims 2
- NWZOSSQOJBZGSI-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C1=CC=C2C=NNC2=C1)C NWZOSSQOJBZGSI-UHFFFAOYSA-N 0.000 claims 2
- BVNDRHCGADDHAI-UHFFFAOYSA-N 6-[4-(3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C1(=CC(=CC=C1)C=1N=CNC=1C1=CC=C2C=NNC2=C1)C BVNDRHCGADDHAI-UHFFFAOYSA-N 0.000 claims 2
- ADMVKBGYFQZRJC-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-2-ethyl-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=CC=2N(C=1)N=CN=2)CC ADMVKBGYFQZRJC-UHFFFAOYSA-N 0.000 claims 2
- ZZQJMQOFGFNOAD-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-2-methyl-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=CC=2N(C=1)C=CN=2)C ZZQJMQOFGFNOAD-UHFFFAOYSA-N 0.000 claims 2
- MHFHMISJNKLOAX-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-3-methylimidazol-4-yl]-1,3-benzothiazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CN(C=1C1=CC2=C(N=CS2)C=C1)C MHFHMISJNKLOAX-UHFFFAOYSA-N 0.000 claims 2
- DCMHIMIXFLDNAZ-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-3-methylimidazol-4-yl]-1-methylbenzimidazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CN(C=1C=1C=CC2=C(N(C=N2)C)C=1)C DCMHIMIXFLDNAZ-UHFFFAOYSA-N 0.000 claims 2
- QCJUTPRRSKOHBM-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-3-methylimidazol-4-yl]-1,3-benzothiazole Chemical compound FC1=C(C=C(C=C1)C=1N=CN(C=1C1=CC2=C(N=CS2)C=C1)C)C QCJUTPRRSKOHBM-UHFFFAOYSA-N 0.000 claims 2
- LPNPTAFOMZXJMQ-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-3-methylimidazol-4-yl]-1-methylbenzimidazole Chemical compound FC1=C(C=C(C=C1)C=1N=CN(C=1C=1C=CC2=C(N(C=N2)C)C=1)C)C LPNPTAFOMZXJMQ-UHFFFAOYSA-N 0.000 claims 2
- INHDCVCKHWQYEP-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(1-hydroxypropan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C(CO)C INHDCVCKHWQYEP-UHFFFAOYSA-N 0.000 claims 2
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 229940122815 Aromatase inhibitor Drugs 0.000 claims 2
- 108010024976 Asparaginase Proteins 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 2
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 claims 2
- 108010006654 Bleomycin Proteins 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 claims 2
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims 2
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 2
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 2
- 201000009030 Carcinoma Diseases 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 2
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 claims 2
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims 2
- 108010092160 Dactinomycin Proteins 0.000 claims 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 2
- 206010061968 Gastric neoplasm Diseases 0.000 claims 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims 2
- JMBQKKAJIKAWKF-UHFFFAOYSA-N Glutethimide Chemical compound C=1C=CC=CC=1C1(CC)CCC(=O)NC1=O JMBQKKAJIKAWKF-UHFFFAOYSA-N 0.000 claims 2
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 2
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 2
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000018565 Hemochromatosis Diseases 0.000 claims 2
- 206010019668 Hepatic fibrosis Diseases 0.000 claims 2
- 208000005176 Hepatitis C Diseases 0.000 claims 2
- DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 claims 2
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- 208000014919 IgG4-related retroperitoneal fibrosis Diseases 0.000 claims 2
- 102000006992 Interferon-alpha Human genes 0.000 claims 2
- 108010047761 Interferon-alpha Proteins 0.000 claims 2
- 102000008070 Interferon-gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 102000014150 Interferons Human genes 0.000 claims 2
- 108010050904 Interferons Proteins 0.000 claims 2
- 208000002260 Keloid Diseases 0.000 claims 2
- 206010023330 Keloid scar Diseases 0.000 claims 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 2
- 239000005517 L01XE01 - Imatinib Substances 0.000 claims 2
- 239000005411 L01XE02 - Gefitinib Substances 0.000 claims 2
- 239000005551 L01XE03 - Erlotinib Substances 0.000 claims 2
- 239000005511 L01XE05 - Sorafenib Substances 0.000 claims 2
- 239000002136 L01XE07 - Lapatinib Substances 0.000 claims 2
- 239000005536 L01XE08 - Nilotinib Substances 0.000 claims 2
- 239000002145 L01XE14 - Bosutinib Substances 0.000 claims 2
- 239000002144 L01XE18 - Ruxolitinib Substances 0.000 claims 2
- 239000002138 L01XE21 - Regorafenib Substances 0.000 claims 2
- XNRVGTHNYCNCFF-UHFFFAOYSA-N Lapatinib ditosylate monohydrate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1.CC1=CC=C(S(O)(=O)=O)C=C1.O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 XNRVGTHNYCNCFF-UHFFFAOYSA-N 0.000 claims 2
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 206010027398 Mesenteric fibrosis Diseases 0.000 claims 2
- 208000034578 Multiple myelomas Diseases 0.000 claims 2
- 101100519207 Mus musculus Pdcd1 gene Proteins 0.000 claims 2
- 108010056852 Myostatin Proteins 0.000 claims 2
- HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 claims 2
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 102000038030 PI3Ks Human genes 0.000 claims 2
- 108091007960 PI3Ks Proteins 0.000 claims 2
- 229930012538 Paclitaxel Natural products 0.000 claims 2
- 206010051246 Photodermatosis Diseases 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 206010051482 Prostatomegaly Diseases 0.000 claims 2
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims 2
- 206010038979 Retroperitoneal fibrosis Diseases 0.000 claims 2
- 206010039491 Sarcoma Diseases 0.000 claims 2
- 229940123237 Taxane Drugs 0.000 claims 2
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 claims 2
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims 2
- 208000025865 Ulcer Diseases 0.000 claims 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 2
- 229940122803 Vinca alkaloid Drugs 0.000 claims 2
- 206010052428 Wound Diseases 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- BCABWNJBVFSNGS-UHFFFAOYSA-N [6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]methanamine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)CN)C1=CC=C(C=C1)F)F BCABWNJBVFSNGS-UHFFFAOYSA-N 0.000 claims 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 210000004100 adrenal gland Anatomy 0.000 claims 2
- 229960001686 afatinib Drugs 0.000 claims 2
- ULXXDDBFHOBEHA-CWDCEQMOSA-N afatinib Chemical compound N1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC1=CC=C(F)C(Cl)=C1 ULXXDDBFHOBEHA-CWDCEQMOSA-N 0.000 claims 2
- 229960000548 alemtuzumab Drugs 0.000 claims 2
- 229940100198 alkylating agent Drugs 0.000 claims 2
- 239000002168 alkylating agent Substances 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 229960001220 amsacrine Drugs 0.000 claims 2
- XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 claims 2
- 230000000340 anti-metabolite Effects 0.000 claims 2
- 229940100197 antimetabolite Drugs 0.000 claims 2
- 239000002256 antimetabolite Substances 0.000 claims 2
- 239000003972 antineoplastic antibiotic Substances 0.000 claims 2
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 claims 2
- 239000003886 aromatase inhibitor Substances 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 229960003005 axitinib Drugs 0.000 claims 2
- RITAVMQDGBJQJZ-FMIVXFBMSA-N axitinib Chemical compound CNC(=O)C1=CC=CC=C1SC1=CC=C(C(\C=C\C=2N=CC=CC=2)=NN2)C2=C1 RITAVMQDGBJQJZ-FMIVXFBMSA-N 0.000 claims 2
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims 2
- 229960002170 azathioprine Drugs 0.000 claims 2
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 claims 2
- ACWZRVQXLIRSDF-UHFFFAOYSA-N binimetinib Chemical compound OCCONC(=O)C=1C=C2N(C)C=NC2=C(F)C=1NC1=CC=C(Br)C=C1F ACWZRVQXLIRSDF-UHFFFAOYSA-N 0.000 claims 2
- 229960001561 bleomycin Drugs 0.000 claims 2
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims 2
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 229960001467 bortezomib Drugs 0.000 claims 2
- GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 claims 2
- 229960003736 bosutinib Drugs 0.000 claims 2
- UBPYILGKFZZVDX-UHFFFAOYSA-N bosutinib Chemical compound C1=C(Cl)C(OC)=CC(NC=2C3=CC(OC)=C(OCCCN4CCN(C)CC4)C=C3N=CC=2C#N)=C1Cl UBPYILGKFZZVDX-UHFFFAOYSA-N 0.000 claims 2
- 229960002092 busulfan Drugs 0.000 claims 2
- 229940127093 camptothecin Drugs 0.000 claims 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 2
- 229960004117 capecitabine Drugs 0.000 claims 2
- 229960004562 carboplatin Drugs 0.000 claims 2
- 229960002438 carfilzomib Drugs 0.000 claims 2
- BLMPQMFVWMYDKT-NZTKNTHTSA-N carfilzomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)[C@]1(C)OC1)NC(=O)CN1CCOCC1)CC1=CC=CC=C1 BLMPQMFVWMYDKT-NZTKNTHTSA-N 0.000 claims 2
- 108010021331 carfilzomib Proteins 0.000 claims 2
- 229960005243 carmustine Drugs 0.000 claims 2
- 229960002412 cediranib Drugs 0.000 claims 2
- 239000002458 cell surface marker Substances 0.000 claims 2
- 229960001602 ceritinib Drugs 0.000 claims 2
- WRXDGGCKOUEOPW-UHFFFAOYSA-N ceritinib Chemical compound CC=1C=C(NC=2N=C(NC=3C(=CC=CC=3)NS(=O)(=O)C(C)C)C(Cl)=CN=2)C(OC(C)C)=CC=1C1CCNCC1 WRXDGGCKOUEOPW-UHFFFAOYSA-N 0.000 claims 2
- 229960005395 cetuximab Drugs 0.000 claims 2
- 229960004630 chlorambucil Drugs 0.000 claims 2
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 claims 2
- 208000020832 chronic kidney disease Diseases 0.000 claims 2
- 229960004316 cisplatin Drugs 0.000 claims 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 2
- 229960002436 cladribine Drugs 0.000 claims 2
- 229960001338 colchicine Drugs 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 229960004397 cyclophosphamide Drugs 0.000 claims 2
- 229960000684 cytarabine Drugs 0.000 claims 2
- 229960003901 dacarbazine Drugs 0.000 claims 2
- 229960000640 dactinomycin Drugs 0.000 claims 2
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims 2
- 229960000975 daunorubicin Drugs 0.000 claims 2
- 208000033679 diabetic kidney disease Diseases 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims 2
- 239000003534 dna topoisomerase inhibitor Substances 0.000 claims 2
- 229960003668 docetaxel Drugs 0.000 claims 2
- 229960004679 doxorubicin Drugs 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 claims 2
- 229960001433 erlotinib Drugs 0.000 claims 2
- AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 claims 2
- 208000030533 eye disease Diseases 0.000 claims 2
- 229960000390 fludarabine Drugs 0.000 claims 2
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 claims 2
- 229960002949 fluorouracil Drugs 0.000 claims 2
- 229960004421 formestane Drugs 0.000 claims 2
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 claims 2
- 229960002584 gefitinib Drugs 0.000 claims 2
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims 2
- 229960000578 gemtuzumab Drugs 0.000 claims 2
- 208000005017 glioblastoma Diseases 0.000 claims 2
- 229960002972 glutethimide Drugs 0.000 claims 2
- 239000003481 heat shock protein 90 inhibitor Substances 0.000 claims 2
- 208000006454 hepatitis Diseases 0.000 claims 2
- 231100000283 hepatitis Toxicity 0.000 claims 2
- 208000002672 hepatitis B Diseases 0.000 claims 2
- 239000003276 histone deacetylase inhibitor Substances 0.000 claims 2
- 229940121372 histone deacetylase inhibitor Drugs 0.000 claims 2
- 229940088597 hormone Drugs 0.000 claims 2
- 239000005556 hormone Substances 0.000 claims 2
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 claims 2
- 229960001101 ifosfamide Drugs 0.000 claims 2
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 2
- 229960002411 imatinib Drugs 0.000 claims 2
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 229940079322 interferon Drugs 0.000 claims 2
- 229960003130 interferon gamma Drugs 0.000 claims 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 2
- 229940036646 iodine-131-tositumomab Drugs 0.000 claims 2
- 229960004768 irinotecan Drugs 0.000 claims 2
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims 2
- 210000001117 keloid Anatomy 0.000 claims 2
- 210000003734 kidney Anatomy 0.000 claims 2
- 229960004891 lapatinib Drugs 0.000 claims 2
- 229960004942 lenalidomide Drugs 0.000 claims 2
- GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical compound C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 claims 2
- CMJCXYNUCSMDBY-ZDUSSCGKSA-N lgx818 Chemical compound COC(=O)N[C@@H](C)CNC1=NC=CC(C=2C(=NN(C=2)C(C)C)C=2C(=C(NS(C)(=O)=O)C=C(Cl)C=2)F)=N1 CMJCXYNUCSMDBY-ZDUSSCGKSA-N 0.000 claims 2
- 210000004185 liver Anatomy 0.000 claims 2
- 229960002247 lomustine Drugs 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 229940124302 mTOR inhibitor Drugs 0.000 claims 2
- 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 claims 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 claims 2
- 229960004961 mechlorethamine Drugs 0.000 claims 2
- 229960004616 medroxyprogesterone Drugs 0.000 claims 2
- FRQMUZJSZHZSGN-HBNHAYAOSA-N medroxyprogesterone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FRQMUZJSZHZSGN-HBNHAYAOSA-N 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 229960000485 methotrexate Drugs 0.000 claims 2
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 claims 2
- 229960001156 mitoxantrone Drugs 0.000 claims 2
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 2
- 230000009251 neurologic dysfunction Effects 0.000 claims 2
- 208000015015 neurological dysfunction Diseases 0.000 claims 2
- 229960001346 nilotinib Drugs 0.000 claims 2
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 claims 2
- 229960003347 obinutuzumab Drugs 0.000 claims 2
- 210000001672 ovary Anatomy 0.000 claims 2
- 229960001592 paclitaxel Drugs 0.000 claims 2
- 210000000496 pancreas Anatomy 0.000 claims 2
- 230000037361 pathway Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 230000008845 photoaging Effects 0.000 claims 2
- 150000003057 platinum Chemical class 0.000 claims 2
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 claims 2
- 229960000624 procarbazine Drugs 0.000 claims 2
- 210000002307 prostate Anatomy 0.000 claims 2
- 239000003207 proteasome inhibitor Substances 0.000 claims 2
- 239000003909 protein kinase inhibitor Substances 0.000 claims 2
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 2
- 208000002815 pulmonary hypertension Diseases 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims 2
- 210000000664 rectum Anatomy 0.000 claims 2
- 229960004836 regorafenib Drugs 0.000 claims 2
- FNHKPVJBJVTLMP-UHFFFAOYSA-N regorafenib Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=C(F)C(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 FNHKPVJBJVTLMP-UHFFFAOYSA-N 0.000 claims 2
- 201000002793 renal fibrosis Diseases 0.000 claims 2
- 208000037803 restenosis Diseases 0.000 claims 2
- 229960004641 rituximab Drugs 0.000 claims 2
- 229960000215 ruxolitinib Drugs 0.000 claims 2
- HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical compound C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 claims 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims 2
- 229960002930 sirolimus Drugs 0.000 claims 2
- 229960003787 sorafenib Drugs 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
- 230000002195 synergetic effect Effects 0.000 claims 2
- 229960001603 tamoxifen Drugs 0.000 claims 2
- 229950007866 tanespimycin Drugs 0.000 claims 2
- AYUNIORJHRXIBJ-TXHRRWQRSA-N tanespimycin Chemical compound N1C(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC2=C(NCC=C)C(=O)C=C1C2=O AYUNIORJHRXIBJ-TXHRRWQRSA-N 0.000 claims 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 2
- 229960004964 temozolomide Drugs 0.000 claims 2
- 229960000235 temsirolimus Drugs 0.000 claims 2
- 229960003433 thalidomide Drugs 0.000 claims 2
- 210000001685 thyroid gland Anatomy 0.000 claims 2
- 229960003087 tioguanine Drugs 0.000 claims 2
- MNRILEROXIRVNJ-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=NC=N[C]21 MNRILEROXIRVNJ-UHFFFAOYSA-N 0.000 claims 2
- 229940044693 topoisomerase inhibitor Drugs 0.000 claims 2
- 229960000303 topotecan Drugs 0.000 claims 2
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 claims 2
- 229960005267 tositumomab Drugs 0.000 claims 2
- 229960004066 trametinib Drugs 0.000 claims 2
- LIRYPHYGHXZJBZ-UHFFFAOYSA-N trametinib Chemical compound CC(=O)NC1=CC=CC(N2C(N(C3CC3)C(=O)C3=C(NC=4C(=CC(I)=CC=4)F)N(C)C(=O)C(C)=C32)=O)=C1 LIRYPHYGHXZJBZ-UHFFFAOYSA-N 0.000 claims 2
- 229960000575 trastuzumab Drugs 0.000 claims 2
- 229960001612 trastuzumab emtansine Drugs 0.000 claims 2
- 125000001425 triazolyl group Chemical group 0.000 claims 2
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims 2
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 2
- 231100000397 ulcer Toxicity 0.000 claims 2
- 210000003932 urinary bladder Anatomy 0.000 claims 2
- 210000001215 vagina Anatomy 0.000 claims 2
- 229960003862 vemurafenib Drugs 0.000 claims 2
- GPXBXXGIAQBQNI-UHFFFAOYSA-N vemurafenib Chemical compound CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C=2C3=CC(=CN=C3NC=2)C=2C=CC(Cl)=CC=2)=C1F GPXBXXGIAQBQNI-UHFFFAOYSA-N 0.000 claims 2
- LQBVNQSMGBZMKD-UHFFFAOYSA-N venetoclax Chemical group C=1C=C(Cl)C=CC=1C=1CC(C)(C)CCC=1CN(CC1)CCN1C(C=C1OC=2C=C3C=CNC3=NC=2)=CC=C1C(=O)NS(=O)(=O)C(C=C1[N+]([O-])=O)=CC=C1NCC1CCOCC1 LQBVNQSMGBZMKD-UHFFFAOYSA-N 0.000 claims 2
- 229960001183 venetoclax Drugs 0.000 claims 2
- 229960003048 vinblastine Drugs 0.000 claims 2
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 2
- 229960004528 vincristine Drugs 0.000 claims 2
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 2
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 2
- 229960000237 vorinostat Drugs 0.000 claims 2
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 claims 2
- 230000029663 wound healing Effects 0.000 claims 2
- XSZSRGQHYNVXJQ-UHFFFAOYSA-N 1-[4-(4-fluorophenyl)-5-imidazo[1,2-b]pyridazin-6-ylimidazol-1-yl]cyclopropane-1-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C=CN=2)C1(CC1)C#N XSZSRGQHYNVXJQ-UHFFFAOYSA-N 0.000 claims 1
- AJMJULFOMPECGE-UHFFFAOYSA-N 1-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridin-3-yl]ethanol Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(C)O)C1=CC=C(C=C1)F)F AJMJULFOMPECGE-UHFFFAOYSA-N 0.000 claims 1
- ZSWBOAJXCVKKMP-UHFFFAOYSA-N 1-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]-2,2,2-trifluoroethanol Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(C(F)(F)F)O)C1=CC=C(C=C1)F)F ZSWBOAJXCVKKMP-UHFFFAOYSA-N 0.000 claims 1
- HKQXCJFYTCVENP-UHFFFAOYSA-N 1-methyl-6-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]benzimidazole Chemical compound CN1C=NC2=C1C=C(C=C2)C1=C(N=CN1C)C=1C=C(C=CC=1)C HKQXCJFYTCVENP-UHFFFAOYSA-N 0.000 claims 1
- GUNDQCGSBHUTRO-UHFFFAOYSA-N 1-tert-butyl-3-[[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]methyl]urea Chemical compound C(C)(C)(C)NC(=O)NCC1=CN=C2N1N=C(C=C2)C1=C(N=CN1CC(F)F)C1=CC=C(C=C1)F GUNDQCGSBHUTRO-UHFFFAOYSA-N 0.000 claims 1
- YFKVHWAIZLRGQD-UHFFFAOYSA-N 2-[5-(3-cyanoimidazo[1,2-b]pyridazin-6-yl)-1-(2,2-difluoroethyl)imidazol-4-yl]benzamide Chemical compound C(#N)C1=CN=C2N1N=C(C=C2)C1=C(N=CN1CC(F)F)C1=C(C(=O)N)C=CC=C1 YFKVHWAIZLRGQD-UHFFFAOYSA-N 0.000 claims 1
- AIWFGWNOBBUPGY-UHFFFAOYSA-N 2-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]ethanol Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)CCO)C1=CC=C(C=C1)F)F AIWFGWNOBBUPGY-UHFFFAOYSA-N 0.000 claims 1
- RRWODQALHOJALX-UHFFFAOYSA-N 2-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]propan-2-ol Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(C)(C)O)C1=CC=C(C=C1)F)F RRWODQALHOJALX-UHFFFAOYSA-N 0.000 claims 1
- GDSCDFKVNOFHNU-UHFFFAOYSA-N 2-[6-[3-cyclopropyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]propan-2-ol Chemical compound C1(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(C)(C)O)C1=CC=C(C=C1)F GDSCDFKVNOFHNU-UHFFFAOYSA-N 0.000 claims 1
- MHRXJXPBCCNJCT-UHFFFAOYSA-N 2-[6-[3-ethyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]propan-2-ol Chemical compound C(C)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(C)(C)O)C1=CC=C(C=C1)F MHRXJXPBCCNJCT-UHFFFAOYSA-N 0.000 claims 1
- 125000000979 2-amino-2-oxoethyl group Chemical group [H]C([*])([H])C(=O)N([H])[H] 0.000 claims 1
- KSXWQTCOOQDZED-UHFFFAOYSA-N 3-[5-(3-cyanoimidazo[1,2-b]pyridazin-6-yl)-1-(2,2-difluoroethyl)imidazol-4-yl]benzamide Chemical compound C(#N)C1=CN=C2N1N=C(C=C2)C1=C(N=CN1CC(F)F)C=1C=C(C(=O)N)C=CC=1 KSXWQTCOOQDZED-UHFFFAOYSA-N 0.000 claims 1
- WRBAQKISFXHMOG-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-(1H-indazol-5-yl)-1,3-thiazol-2-amine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(SC=1C=1C=C2C=NNC2=CC=1)N WRBAQKISFXHMOG-UHFFFAOYSA-N 0.000 claims 1
- XYJCDMWGXVHSQC-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-(1H-indazol-6-yl)-1,3-thiazol-2-amine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(SC=1C1=CC=C2C=NNC2=C1)N XYJCDMWGXVHSQC-UHFFFAOYSA-N 0.000 claims 1
- XQWMRHMCKURFEF-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-imidazo[1,2-a]pyridin-6-yl-1,3-thiazol-2-amine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(SC=1C=1C=CC=2N(C=1)C=CN=2)N XQWMRHMCKURFEF-UHFFFAOYSA-N 0.000 claims 1
- XWZLIASLMMFLKY-UHFFFAOYSA-N 4-(3-chlorophenyl)-5-quinoxalin-6-yl-1,3-thiazol-2-amine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(SC=1C=1C=C2N=CC=NC2=CC=1)N XWZLIASLMMFLKY-UHFFFAOYSA-N 0.000 claims 1
- XOUYSYBNYUDGFJ-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-(1H-indazol-5-yl)-1,3-thiazol-2-amine Chemical compound FC=1C=C(C=CC=1)C=1N=C(SC=1C=1C=C2C=NNC2=CC=1)N XOUYSYBNYUDGFJ-UHFFFAOYSA-N 0.000 claims 1
- UVKPYIXZZSSKNE-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-imidazo[1,2-a]pyridin-6-yl-1,3-thiazol-2-amine Chemical compound FC=1C=C(C=CC=1)C=1N=C(SC=1C=1C=CC=2N(C=1)C=CN=2)N UVKPYIXZZSSKNE-UHFFFAOYSA-N 0.000 claims 1
- TVIFTGYLIXEDMO-UHFFFAOYSA-N 4-(3-fluorophenyl)-5-quinoxalin-6-yl-1,3-thiazol-2-amine Chemical compound FC=1C=C(C=CC=1)C=1N=C(SC=1C=1C=C2N=CC=NC2=CC=1)N TVIFTGYLIXEDMO-UHFFFAOYSA-N 0.000 claims 1
- MBTBKTUBSVPUIO-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-(1H-indazol-5-yl)-1,3-thiazol-2-amine Chemical compound FC1=C(C=C(C=C1)C=1N=C(SC=1C=1C=C2C=NNC2=CC=1)N)C MBTBKTUBSVPUIO-UHFFFAOYSA-N 0.000 claims 1
- FJVHTVZRXPBSBZ-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-(1H-indazol-5-yl)-1,3-thiazole Chemical compound FC1=C(C=C(C=C1)C=1N=CSC=1C=1C=C2C=NNC2=CC=1)C FJVHTVZRXPBSBZ-UHFFFAOYSA-N 0.000 claims 1
- HYUKHBFCEQICQT-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-(1H-indazol-6-yl)-1,3-thiazol-2-amine Chemical compound FC1=C(C=C(C=C1)C=1N=C(SC=1C1=CC=C2C=NNC2=C1)N)C HYUKHBFCEQICQT-UHFFFAOYSA-N 0.000 claims 1
- HARYPUZEHVRHQY-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-(1H-indazol-6-yl)-1,3-thiazole Chemical compound FC1=C(C=C(C=C1)C=1N=CSC=1C1=CC=C2C=NNC2=C1)C HARYPUZEHVRHQY-UHFFFAOYSA-N 0.000 claims 1
- ZBYGIDSFYNLRKY-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-imidazo[1,2-a]pyridin-6-yl-1,3-thiazol-2-amine Chemical compound FC1=C(C=C(C=C1)C=1N=C(SC=1C=1C=CC=2N(C=1)C=CN=2)N)C ZBYGIDSFYNLRKY-UHFFFAOYSA-N 0.000 claims 1
- ZXPJODCURDADDE-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-imidazo[1,2-a]pyridin-6-yl-1,3-thiazole Chemical compound FC1=C(C=C(C=C1)C=1N=CSC=1C=1C=CC=2N(C=1)C=CN=2)C ZXPJODCURDADDE-UHFFFAOYSA-N 0.000 claims 1
- DGBQNIPEZHEMTL-UHFFFAOYSA-N 4-(4-fluoro-3-methylphenyl)-5-quinoxalin-6-yl-1,3-thiazol-2-amine Chemical compound FC1=C(C=C(C=C1)C=1N=C(SC=1C=1C=C2N=CC=NC2=CC=1)N)C DGBQNIPEZHEMTL-UHFFFAOYSA-N 0.000 claims 1
- QKCSTEXPEQCHFD-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-imidazo[1,2-a]pyridin-6-yl-N-methyl-1,3-thiazol-2-amine Chemical compound FC1=CC=C(C=C1)C=1N=C(SC=1C=1C=CC=2N(C=1)C=CN=2)NC QKCSTEXPEQCHFD-UHFFFAOYSA-N 0.000 claims 1
- JTVHMVJESDQZRC-UHFFFAOYSA-N 4-(4-fluorophenyl)-5-quinoxalin-6-yl-1,3-thiazol-2-amine Chemical compound FC1=CC=C(C=C1)C=1N=C(SC=1C=1C=C2N=CC=NC2=CC=1)N JTVHMVJESDQZRC-UHFFFAOYSA-N 0.000 claims 1
- QEEFBYDENWVPIH-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-quinoxalin-6-yl-1,3-thiazol-2-amine Chemical compound COC1=CC=C(C=C1)C=1N=C(SC=1C=1C=C2N=CC=NC2=CC=1)N QEEFBYDENWVPIH-UHFFFAOYSA-N 0.000 claims 1
- FRGQJEZFWPDEFR-UHFFFAOYSA-N 4-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridin-3-yl]morpholine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)N1CCOCC1)C1=CC=C(C=C1)F)F FRGQJEZFWPDEFR-UHFFFAOYSA-N 0.000 claims 1
- XTCRWGHXLJUEHZ-UHFFFAOYSA-N 5-(1,3-benzothiazol-6-yl)-4-(3-fluorophenyl)-1,3-thiazol-2-amine Chemical compound S1C=NC2=C1C=C(C=C2)C1=C(N=C(S1)N)C1=CC(=CC=C1)F XTCRWGHXLJUEHZ-UHFFFAOYSA-N 0.000 claims 1
- KRGYNLYPMNDKGL-UHFFFAOYSA-N 5-(1,3-benzothiazol-6-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound S1C=NC2=C1C=C(C=C2)C1=C(N=C(S1)N)C1=CC(=CC=C1)OC KRGYNLYPMNDKGL-UHFFFAOYSA-N 0.000 claims 1
- DNONCWACNKPEIA-UHFFFAOYSA-N 5-(1,3-benzothiazol-6-yl)-4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-amine Chemical compound S1C=NC2=C1C=C(C=C2)C1=C(N=C(S1)N)C1=CC(=C(C=C1)F)C DNONCWACNKPEIA-UHFFFAOYSA-N 0.000 claims 1
- NGKHUSFETWGMRD-UHFFFAOYSA-N 5-(1,3-benzothiazol-6-yl)-4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine Chemical compound S1C=NC2=C1C=C(C=C2)C1=C(N=C(S1)N)C1=CC(=CC=C1)C(F)(F)F NGKHUSFETWGMRD-UHFFFAOYSA-N 0.000 claims 1
- JRYWZGRWXAGQBJ-UHFFFAOYSA-N 5-(1H-indazol-5-yl)-4-(3-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound N1N=CC2=CC(=CC=C12)C1=C(N=C(S1)N)C1=CC(=CC=C1)OC JRYWZGRWXAGQBJ-UHFFFAOYSA-N 0.000 claims 1
- IXGXXRPDORFISE-UHFFFAOYSA-N 5-(1H-indazol-5-yl)-4-(3-methylphenyl)-1,3-thiazole Chemical compound N1N=CC2=CC(=CC=C12)C1=C(N=CS1)C=1C=C(C=CC=1)C IXGXXRPDORFISE-UHFFFAOYSA-N 0.000 claims 1
- ZQIIFDOKGJNHAA-UHFFFAOYSA-N 5-(1H-indazol-5-yl)-4-(4-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound N1N=CC2=CC(=CC=C12)C1=C(N=C(S1)N)C1=CC=C(C=C1)OC ZQIIFDOKGJNHAA-UHFFFAOYSA-N 0.000 claims 1
- PDDKAQIFISVWGF-UHFFFAOYSA-N 5-(1H-indazol-5-yl)-4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine Chemical compound N1N=CC2=CC(=CC=C12)C1=C(N=C(S1)N)C1=CC(=CC=C1)C(F)(F)F PDDKAQIFISVWGF-UHFFFAOYSA-N 0.000 claims 1
- KMQHYBPRWZXRLY-UHFFFAOYSA-N 5-(1H-indazol-6-yl)-4-(3-methylphenyl)-1,3-thiazole Chemical compound N1N=CC2=CC=C(C=C12)C1=C(N=CS1)C=1C=C(C=CC=1)C KMQHYBPRWZXRLY-UHFFFAOYSA-N 0.000 claims 1
- FZVBATVNUIRHKI-UHFFFAOYSA-N 5-(1H-indazol-6-yl)-4-(4-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound N1N=CC2=CC=C(C=C12)C1=C(N=C(S1)N)C1=CC=C(C=C1)OC FZVBATVNUIRHKI-UHFFFAOYSA-N 0.000 claims 1
- GRMXALLBGWQEAY-UHFFFAOYSA-N 5-(1H-indazol-6-yl)-4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine Chemical compound N1N=CC2=CC=C(C=C12)C1=C(N=C(S1)N)C1=CC(=CC=C1)C(F)(F)F GRMXALLBGWQEAY-UHFFFAOYSA-N 0.000 claims 1
- SRVKIGXQENKXHA-UHFFFAOYSA-N 5-[2,3-dimethyl-5-(3-methylphenyl)imidazol-4-yl]-1H-indazole Chemical compound CN1C(=NC(=C1C=1C=C2C=NNC2=CC=1)C=1C=C(C=CC=1)C)C SRVKIGXQENKXHA-UHFFFAOYSA-N 0.000 claims 1
- SZJXGQDYVIWIGQ-UHFFFAOYSA-N 5-[2-ethyl-4-(3-fluoro-5-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC(=C1)C)F)C=1C=C2C=NNC2=CC=1 SZJXGQDYVIWIGQ-UHFFFAOYSA-N 0.000 claims 1
- KJEDFYRIYBTZEU-UHFFFAOYSA-N 5-[2-ethyl-4-(3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C=1C=C2C=NNC2=CC=1 KJEDFYRIYBTZEU-UHFFFAOYSA-N 0.000 claims 1
- GXVPBJHVMNRGLS-UHFFFAOYSA-N 5-[2-ethyl-4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C=1C=C2C=NNC2=CC=1 GXVPBJHVMNRGLS-UHFFFAOYSA-N 0.000 claims 1
- JUIXZQZFWQBMFQ-UHFFFAOYSA-N 5-[2-ethyl-5-(4-fluorophenyl)-1H-imidazol-4-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC=C(C=C1)F)C=1C=C2C=NNC2=CC=1 JUIXZQZFWQBMFQ-UHFFFAOYSA-N 0.000 claims 1
- PKLBMOWTYHIFQU-UHFFFAOYSA-N 5-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C=1C=C2C=NNC2=CC=1 PKLBMOWTYHIFQU-UHFFFAOYSA-N 0.000 claims 1
- UFWJAQOSHUFCAV-UHFFFAOYSA-N 5-[2-methyl-5-(2,4,5-trifluorophenyl)-1H-imidazol-4-yl]-1H-indazole Chemical compound CC=1NC(=C(N=1)C1=C(C=C(C(=C1)F)F)F)C=1C=C2C=NNC2=CC=1 UFWJAQOSHUFCAV-UHFFFAOYSA-N 0.000 claims 1
- VMVJVKXRKUIMHJ-UHFFFAOYSA-N 5-[4-(3,4-difluorophenyl)-2-ethyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)CC VMVJVKXRKUIMHJ-UHFFFAOYSA-N 0.000 claims 1
- ODLGSIGBWRWNQE-UHFFFAOYSA-N 5-[4-(3,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)C ODLGSIGBWRWNQE-UHFFFAOYSA-N 0.000 claims 1
- FJHHRIUKXFGXNF-UHFFFAOYSA-N 5-[4-(3,5-difluorophenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=C(C=1)F)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)C FJHHRIUKXFGXNF-UHFFFAOYSA-N 0.000 claims 1
- NLULSMRBQBEKJT-UHFFFAOYSA-N 5-[4-(3-chloro-5-fluorophenyl)-2-ethyl-1H-imidazol-5-yl]-1H-indazole Chemical compound ClC=1C=C(C=C(C=1)F)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)CC NLULSMRBQBEKJT-UHFFFAOYSA-N 0.000 claims 1
- UMKNNASRAKDBQO-UHFFFAOYSA-N 5-[4-(3-chlorophenyl)-2-ethyl-1H-imidazol-5-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)CC UMKNNASRAKDBQO-UHFFFAOYSA-N 0.000 claims 1
- NWSNYQSZTHBTDY-UHFFFAOYSA-N 5-[4-(3-chlorophenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)C NWSNYQSZTHBTDY-UHFFFAOYSA-N 0.000 claims 1
- DYRLKYKREPMBKO-UHFFFAOYSA-N 5-[5-(4-fluoro-3-methylphenyl)-2,3-dimethylimidazol-4-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(N(C=1C=1C=C2C=NNC2=CC=1)C)C)C DYRLKYKREPMBKO-UHFFFAOYSA-N 0.000 claims 1
- CORDRCXPMDTNBX-UHFFFAOYSA-N 5-[5-(4-fluorophenyl)-2-methyl-1H-imidazol-4-yl]-1H-indazole Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C=1C=C2C=NNC2=CC=1)C CORDRCXPMDTNBX-UHFFFAOYSA-N 0.000 claims 1
- ZAJBVEHYCSELCV-UHFFFAOYSA-N 5-[5-(4-fluorophenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=C2C=NNC2=CC=1)C ZAJBVEHYCSELCV-UHFFFAOYSA-N 0.000 claims 1
- HWSOZSXZHXYROJ-UHFFFAOYSA-N 5-[5-(4-methoxyphenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound COC1=CC=C(C=C1)C=1N=CN(C=1C=1C=C2C=NNC2=CC=1)C HWSOZSXZHXYROJ-UHFFFAOYSA-N 0.000 claims 1
- FFARGLZRLVWCLR-UHFFFAOYSA-N 5-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]-1,3-oxazole Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C1=CN=CO1)C1=CC=C(C=C1)F)F FFARGLZRLVWCLR-UHFFFAOYSA-N 0.000 claims 1
- YLPYFINBHMOROE-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-6-yl-4-(3-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound N=1C=CN2C=1C=CC(=C2)C1=C(N=C(S1)N)C1=CC(=CC=C1)OC YLPYFINBHMOROE-UHFFFAOYSA-N 0.000 claims 1
- MYOBUZFNZHPMCI-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-6-yl-4-(4-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound N=1C=CN2C=1C=CC(=C2)C1=C(N=C(S1)N)C1=CC=C(C=C1)OC MYOBUZFNZHPMCI-UHFFFAOYSA-N 0.000 claims 1
- NJCSPSNHDMOLMN-UHFFFAOYSA-N 5-imidazo[1,2-a]pyridin-6-yl-4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine Chemical compound N=1C=CN2C=1C=CC(=C2)C1=C(N=C(S1)N)C1=CC(=CC=C1)C(F)(F)F NJCSPSNHDMOLMN-UHFFFAOYSA-N 0.000 claims 1
- XQXQMMZOEQAJAX-UHFFFAOYSA-N 5-quinoxalin-6-yl-4-[3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine Chemical compound N1=CC=NC2=CC(=CC=C12)C1=C(N=C(S1)N)C1=CC(=CC=C1)C(F)(F)F XQXQMMZOEQAJAX-UHFFFAOYSA-N 0.000 claims 1
- DGWOCDSEKXZKBT-UHFFFAOYSA-N 6-[2,3-dimethyl-5-(3-methylphenyl)imidazol-4-yl]-1,3-benzothiazole Chemical compound CN1C(=NC(=C1C1=CC2=C(N=CS2)C=C1)C=1C=C(C=CC=1)C)C DGWOCDSEKXZKBT-UHFFFAOYSA-N 0.000 claims 1
- TWZWVVDYGDEDTC-UHFFFAOYSA-N 6-[2,3-dimethyl-5-(3-methylphenyl)imidazol-4-yl]-1-methylbenzimidazole Chemical compound CN1C(=NC(=C1C=1C=CC2=C(N(C=N2)C)C=1)C=1C=C(C=CC=1)C)C TWZWVVDYGDEDTC-UHFFFAOYSA-N 0.000 claims 1
- JJJQNLUGCAPGSZ-UHFFFAOYSA-N 6-[2,3-dimethyl-5-(3-methylphenyl)imidazol-4-yl]-1H-indazole Chemical compound CN1C(=NC(=C1C1=CC=C2C=NNC2=C1)C=1C=C(C=CC=1)C)C JJJQNLUGCAPGSZ-UHFFFAOYSA-N 0.000 claims 1
- CAGUYNPICDXDAT-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=C2N(CCNC2)C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N CAGUYNPICDXDAT-UHFFFAOYSA-N 0.000 claims 1
- OPHLMHLJLIXRDE-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=C2N(C=1C=1C=CC=3N(C=1)C(=CN=3)C#N)CCC2 OPHLMHLJLIXRDE-UHFFFAOYSA-N 0.000 claims 1
- ZCVUZZMCWLHUTN-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=C2N(C=1C=1C=CC=3N(C=1)C(=CN=3)C(=O)N)CCC2 ZCVUZZMCWLHUTN-UHFFFAOYSA-N 0.000 claims 1
- WPSPFTKBUPMYAT-UHFFFAOYSA-N 6-[2-(4-fluorophenyl)-7-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=C2N(CCN(C2)C)C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N WPSPFTKBUPMYAT-UHFFFAOYSA-N 0.000 claims 1
- YGXPXWXYMBIYBJ-UHFFFAOYSA-N 6-[2-amino-3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound NC=1N(C(=C(N=1)C1=CC=C(C=C1)F)C=1C=CC=2N(C=1)C(=CN=2)C#N)CC(F)F YGXPXWXYMBIYBJ-UHFFFAOYSA-N 0.000 claims 1
- NZYHESAHFRPMAQ-UHFFFAOYSA-N 6-[2-ethyl-4-(3-fluoro-5-methylphenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC(=C1)C)F)C1=CC2=C(N=CS2)C=C1 NZYHESAHFRPMAQ-UHFFFAOYSA-N 0.000 claims 1
- KHCNWTOONOFPQA-UHFFFAOYSA-N 6-[2-ethyl-4-(3-fluoro-5-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC(=C1)C)F)C1=CC=C2C=NNC2=C1 KHCNWTOONOFPQA-UHFFFAOYSA-N 0.000 claims 1
- HDRDJZPTUDDSNF-UHFFFAOYSA-N 6-[2-ethyl-4-(3-fluoro-5-methylphenyl)-1H-imidazol-5-yl]imidazo[1,2-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC(=C1)C)F)C=1C=CC=2N(C=1)C=CN=2 HDRDJZPTUDDSNF-UHFFFAOYSA-N 0.000 claims 1
- YQPGVGZUDXJINE-UHFFFAOYSA-N 6-[2-ethyl-4-(3-fluoro-5-methylphenyl)-1H-imidazol-5-yl]quinoxaline Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC(=C1)C)F)C=1C=C2N=CC=NC2=CC=1 YQPGVGZUDXJINE-UHFFFAOYSA-N 0.000 claims 1
- YKKWKVSSIBDNQT-UHFFFAOYSA-N 6-[2-ethyl-4-(3-fluorophenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC=C1)F)C1=CC2=C(N=CS2)C=C1 YKKWKVSSIBDNQT-UHFFFAOYSA-N 0.000 claims 1
- JACDLXPLEQFBQJ-UHFFFAOYSA-N 6-[2-ethyl-4-(3-methylphenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound C(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C1=CC2=C(N=CS2)C=C1 JACDLXPLEQFBQJ-UHFFFAOYSA-N 0.000 claims 1
- FOJNQQMEEXTXMC-UHFFFAOYSA-N 6-[2-ethyl-4-(3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C1=CC=C2C=NNC2=C1 FOJNQQMEEXTXMC-UHFFFAOYSA-N 0.000 claims 1
- ZWTQGYQENJTHQB-UHFFFAOYSA-N 6-[2-ethyl-4-(3-methylphenyl)-1H-imidazol-5-yl]quinoxaline Chemical compound C(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C=1C=C2N=CC=NC2=CC=1 ZWTQGYQENJTHQB-UHFFFAOYSA-N 0.000 claims 1
- BTMBSOKJUCONCV-UHFFFAOYSA-N 6-[2-ethyl-4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C1=CC2=C(N=CS2)C=C1 BTMBSOKJUCONCV-UHFFFAOYSA-N 0.000 claims 1
- DLOUVWMIAXHHQX-UHFFFAOYSA-N 6-[2-ethyl-4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C1=CC=C2C=NNC2=C1 DLOUVWMIAXHHQX-UHFFFAOYSA-N 0.000 claims 1
- LIKBZTZESCKFFS-UHFFFAOYSA-N 6-[2-ethyl-4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]quinoline Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C=1C=C2C=CC=NC2=CC=1 LIKBZTZESCKFFS-UHFFFAOYSA-N 0.000 claims 1
- PICAYFKWZQCFIF-UHFFFAOYSA-N 6-[2-ethyl-4-(4-fluoro-3-methylphenyl)-1H-imidazol-5-yl]quinoxaline Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C=1C=C2N=CC=NC2=CC=1 PICAYFKWZQCFIF-UHFFFAOYSA-N 0.000 claims 1
- LQDTYCGRESGYMP-UHFFFAOYSA-N 6-[2-ethyl-5-(3-fluorophenyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC=C1)F)C=1C=CC=2N(C=1)N=CN=2 LQDTYCGRESGYMP-UHFFFAOYSA-N 0.000 claims 1
- BWMSLTXVKOEJHM-UHFFFAOYSA-N 6-[2-ethyl-5-(3-fluorophenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=CC=C1)F)C=1C=CC=2N(C=1)C=CN=2 BWMSLTXVKOEJHM-UHFFFAOYSA-N 0.000 claims 1
- QRRYAIVGAHXSHB-UHFFFAOYSA-N 6-[2-ethyl-5-(3-methylphenyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C=1C=CC=2N(C=1)N=CN=2 QRRYAIVGAHXSHB-UHFFFAOYSA-N 0.000 claims 1
- WGCXWBRRPBIEHQ-UHFFFAOYSA-N 6-[2-ethyl-5-(3-methylphenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C=1C=CC=2N(C=1)C=CN=2 WGCXWBRRPBIEHQ-UHFFFAOYSA-N 0.000 claims 1
- OOEXUGOKZXYWOU-UHFFFAOYSA-N 6-[2-ethyl-5-(4-fluoro-3-methylphenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC(=C(C=C1)F)C)C=1C=CC=2N(C=1)C=CN=2 OOEXUGOKZXYWOU-UHFFFAOYSA-N 0.000 claims 1
- VJWXAJCEZGEWFX-UHFFFAOYSA-N 6-[2-ethyl-5-(4-fluorophenyl)-1H-imidazol-4-yl]-1,3-benzothiazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC=C(C=C1)F)C1=CC2=C(N=CS2)C=C1 VJWXAJCEZGEWFX-UHFFFAOYSA-N 0.000 claims 1
- VJRVZPDUPQHHMR-UHFFFAOYSA-N 6-[2-ethyl-5-(4-fluorophenyl)-1H-imidazol-4-yl]-1H-indazole Chemical compound C(C)C=1NC(=C(N=1)C1=CC=C(C=C1)F)C1=CC=C2C=NNC2=C1 VJRVZPDUPQHHMR-UHFFFAOYSA-N 0.000 claims 1
- DBKXPJVDAVYWDR-UHFFFAOYSA-N 6-[2-ethyl-5-(4-fluorophenyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC=C(C=C1)F)C=1C=CC=2N(C=1)N=CN=2 DBKXPJVDAVYWDR-UHFFFAOYSA-N 0.000 claims 1
- SKLWRNIQQOCJMF-UHFFFAOYSA-N 6-[2-ethyl-5-(4-fluorophenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound C(C)C=1NC(=C(N=1)C1=CC=C(C=C1)F)C=1C=CC=2N(C=1)C=CN=2 SKLWRNIQQOCJMF-UHFFFAOYSA-N 0.000 claims 1
- WTOAWJPAUILHGA-UHFFFAOYSA-N 6-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C1=CC2=C(N=CS2)C=C1 WTOAWJPAUILHGA-UHFFFAOYSA-N 0.000 claims 1
- XAFWIYNOPDLJFD-UHFFFAOYSA-N 6-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]-1H-indazole Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C1=CC=C2C=NNC2=C1 XAFWIYNOPDLJFD-UHFFFAOYSA-N 0.000 claims 1
- QURSFSYITQOBRJ-UHFFFAOYSA-N 6-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C=1C=CC=2N(C=1)N=CN=2 QURSFSYITQOBRJ-UHFFFAOYSA-N 0.000 claims 1
- QDFDKUYNPJIJLY-UHFFFAOYSA-N 6-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]imidazo[1,2-a]pyridine Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C=1C=CC=2N(C=1)C=CN=2 QDFDKUYNPJIJLY-UHFFFAOYSA-N 0.000 claims 1
- NSRYFRPHASLGHF-UHFFFAOYSA-N 6-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]quinoline Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C=1C=C2C=CC=NC2=CC=1 NSRYFRPHASLGHF-UHFFFAOYSA-N 0.000 claims 1
- QQNXJRSNSXHWSH-UHFFFAOYSA-N 6-[2-methyl-4-(3,4,5-trifluorophenyl)-1H-imidazol-5-yl]quinoxaline Chemical compound CC=1NC(=C(N=1)C1=CC(=C(C(=C1)F)F)F)C=1C=C2N=CC=NC2=CC=1 QQNXJRSNSXHWSH-UHFFFAOYSA-N 0.000 claims 1
- XTUQMFBGWWBBJK-UHFFFAOYSA-N 6-[2-methyl-5-(2,4,5-trifluorophenyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC=1NC(=C(N=1)C1=C(C=C(C(=C1)F)F)F)C=1C=CC=2N(C=1)N=CN=2 XTUQMFBGWWBBJK-UHFFFAOYSA-N 0.000 claims 1
- CNPBZTMRYQNDOU-UHFFFAOYSA-N 6-[2-methyl-5-(2,4,5-trifluorophenyl)-1H-imidazol-4-yl]quinoline Chemical compound CC=1NC(=C(N=1)C1=C(C=C(C(=C1)F)F)F)C=1C=C2C=CC=NC2=CC=1 CNPBZTMRYQNDOU-UHFFFAOYSA-N 0.000 claims 1
- VCBNLUPJBCSCOI-UHFFFAOYSA-N 6-[3-(1,3-dihydroxypropan-2-yl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound OCC(CO)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F VCBNLUPJBCSCOI-UHFFFAOYSA-N 0.000 claims 1
- FPQLGUMJFUYAFN-UHFFFAOYSA-N 6-[3-(1,3-dihydroxypropan-2-yl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound OCC(CO)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F FPQLGUMJFUYAFN-UHFFFAOYSA-N 0.000 claims 1
- YFOHJUJSIYYBDD-UHFFFAOYSA-N 6-[3-(1,3-dihydroxypropan-2-yl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound OCC(CO)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F YFOHJUJSIYYBDD-UHFFFAOYSA-N 0.000 claims 1
- AZRNPAKJOHMERK-UHFFFAOYSA-N 6-[3-(1-acetylazetidin-3-yl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(C)(=O)N1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F AZRNPAKJOHMERK-UHFFFAOYSA-N 0.000 claims 1
- IUJYDCJZGPLXMG-UHFFFAOYSA-N 6-[3-(1-bicyclo[1.1.1]pentanyl)-5-(3-chloro-4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C12(CC(C1)C2)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=C(C=C1)F)Cl IUJYDCJZGPLXMG-UHFFFAOYSA-N 0.000 claims 1
- TYCJMGOOBHRJHI-UHFFFAOYSA-N 6-[3-(1-bicyclo[1.1.1]pentanyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C12(CC(C1)C2)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F TYCJMGOOBHRJHI-UHFFFAOYSA-N 0.000 claims 1
- UJNMZRXOWLNRHS-UHFFFAOYSA-N 6-[3-(1-bicyclo[1.1.1]pentanyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C12(CC(C1)C2)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F UJNMZRXOWLNRHS-UHFFFAOYSA-N 0.000 claims 1
- QDUBUKBLTBLKSO-UHFFFAOYSA-N 6-[3-(1-cyanocyclopropyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(#N)C1(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F QDUBUKBLTBLKSO-UHFFFAOYSA-N 0.000 claims 1
- PGONIWNMIBAILF-UHFFFAOYSA-N 6-[3-(1-cyclopropyl-2-methoxyethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C1(CC1)C(COC)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F PGONIWNMIBAILF-UHFFFAOYSA-N 0.000 claims 1
- NLUJQDXABWQMJS-UHFFFAOYSA-N 6-[3-(1-cyclopropyl-2-methoxyethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C1(CC1)C(COC)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F NLUJQDXABWQMJS-UHFFFAOYSA-N 0.000 claims 1
- DOBJVBKFVLTKAL-UHFFFAOYSA-N 6-[3-(1-cyclopropylethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound C1(CC1)C(C)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F DOBJVBKFVLTKAL-UHFFFAOYSA-N 0.000 claims 1
- UGSLCDQDLRUZKO-UHFFFAOYSA-N 6-[3-(1-cyclopropylethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C1(CC1)C(C)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F UGSLCDQDLRUZKO-UHFFFAOYSA-N 0.000 claims 1
- SMOTXXNJTKFBCS-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(2,4-difluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=C(C=C(C=C1)F)F)F SMOTXXNJTKFBCS-UHFFFAOYSA-N 0.000 claims 1
- PAKCNVNTMXVNCV-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(2,4-difluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=C(C=C(C=C1)F)F)F PAKCNVNTMXVNCV-UHFFFAOYSA-N 0.000 claims 1
- BYNUJHIHRYVHIS-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(2-hydroxyphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=C(C=CC=C1)O)F BYNUJHIHRYVHIS-UHFFFAOYSA-N 0.000 claims 1
- NTCSHTNPWNGGBF-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(3,4-difluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC(=C(C=C1)F)F)F NTCSHTNPWNGGBF-UHFFFAOYSA-N 0.000 claims 1
- MWIQHEVSSSWADG-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(3,4-difluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC(=C(C=C1)F)F)F MWIQHEVSSSWADG-UHFFFAOYSA-N 0.000 claims 1
- LKIOFJKRLNXCHM-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(3-hydroxyphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=CC=C1)O)F LKIOFJKRLNXCHM-UHFFFAOYSA-N 0.000 claims 1
- PZPFXNOFLVGPKQ-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(3-methylsulfonylphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=CC=C1)S(=O)(=O)C)F PZPFXNOFLVGPKQ-UHFFFAOYSA-N 0.000 claims 1
- XGHUABGSFRCSGP-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(3-phenylphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C1(=CC(=CC=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F)C1=CC=CC=C1 XGHUABGSFRCSGP-UHFFFAOYSA-N 0.000 claims 1
- VBTGRKWAIXSXHJ-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluoro-3-methoxyphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=C(C=C1)F)OC)F VBTGRKWAIXSXHJ-UHFFFAOYSA-N 0.000 claims 1
- AVPQSLGTDARBKX-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)-2-methylimidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC(CN1C(=NC(=C1C=1C=CC=2N(C=1)C=CN=2)C1=CC=C(C=C1)F)C)F AVPQSLGTDARBKX-UHFFFAOYSA-N 0.000 claims 1
- NQWJSRHHQHKHCL-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)-2-methylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC(CN1C(=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)C)F NQWJSRHHQHKHCL-UHFFFAOYSA-N 0.000 claims 1
- DJHKEYQVGKZTMP-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)-2-methylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC(CN1C(=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)C)F DJHKEYQVGKZTMP-UHFFFAOYSA-N 0.000 claims 1
- RNLANHFGNKVDNG-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]-3-(difluoromethyl)imidazo[1,2-a]pyridine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(F)F)C1=CC=C(C=C1)F)F RNLANHFGNKVDNG-UHFFFAOYSA-N 0.000 claims 1
- HZXCIXSJCJHRJV-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]-3-ethenylimidazo[1,2-b]pyridazine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C=C)C1=CC=C(C=C1)F)F HZXCIXSJCJHRJV-UHFFFAOYSA-N 0.000 claims 1
- QBRYOGARJOUITH-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]-3-fluoroimidazo[1,2-a]pyridine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)F)C1=CC=C(C=C1)F)F QBRYOGARJOUITH-UHFFFAOYSA-N 0.000 claims 1
- RWDMPAOHRFJLAV-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]-N-methoxyimidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)NOC)C1=CC=C(C=C1)F)F RWDMPAOHRFJLAV-UHFFFAOYSA-N 0.000 claims 1
- UHRYMDJRYFXYNF-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]-N-methylimidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)NC)C1=CC=C(C=C1)F)F UHRYMDJRYFXYNF-UHFFFAOYSA-N 0.000 claims 1
- TXXPSLXUMHXSFY-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridin-3-amine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)N)C1=CC=C(C=C1)F)F TXXPSLXUMHXSFY-UHFFFAOYSA-N 0.000 claims 1
- ROVRIANNXYZMFP-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)F ROVRIANNXYZMFP-UHFFFAOYSA-N 0.000 claims 1
- SVQPVXHAXIOYAF-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)F SVQPVXHAXIOYAF-UHFFFAOYSA-N 0.000 claims 1
- XLZKVXCANGOASB-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbohydrazide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)NN)C1=CC=C(C=C1)F)F XLZKVXCANGOASB-UHFFFAOYSA-N 0.000 claims 1
- DKKDSRACISNOLY-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)F DKKDSRACISNOLY-UHFFFAOYSA-N 0.000 claims 1
- QSHIZQDRTANCSB-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-hydroxyphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)O)F QSHIZQDRTANCSB-UHFFFAOYSA-N 0.000 claims 1
- NHLDFZIDIQCYDI-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-methoxyphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)OC)F NHLDFZIDIQCYDI-UHFFFAOYSA-N 0.000 claims 1
- ZOIBRGBNNBIPMM-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-methylphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)C)F ZOIBRGBNNBIPMM-UHFFFAOYSA-N 0.000 claims 1
- ZZDYBGUMEVRYOV-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-(4-propan-2-yloxyphenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)OC(C)C)F ZZDYBGUMEVRYOV-UHFFFAOYSA-N 0.000 claims 1
- YNPLOFDWPKMUIZ-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[2-(hydroxymethyl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=C(C=CC=C1)CO)F YNPLOFDWPKMUIZ-UHFFFAOYSA-N 0.000 claims 1
- LCAOAERTWRJUNY-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[3-(2-hydroxypropan-2-yl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=CC=C1)C(C)(C)O)F LCAOAERTWRJUNY-UHFFFAOYSA-N 0.000 claims 1
- HIZKQJCHZWYQGG-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[3-(hydroxymethyl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=CC=C1)CO)F HIZKQJCHZWYQGG-UHFFFAOYSA-N 0.000 claims 1
- KTYXJOHTTOOMEL-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[3-(trifluoromethoxy)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=CC=C1)OC(F)(F)F)F KTYXJOHTTOOMEL-UHFFFAOYSA-N 0.000 claims 1
- MVJOBKYLZZMYHP-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=CC=C1)C(F)(F)F)F MVJOBKYLZZMYHP-UHFFFAOYSA-N 0.000 claims 1
- UGBGZGUCQHWFOS-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[4-(trifluoromethyl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)C(F)(F)F)F UGBGZGUCQHWFOS-UHFFFAOYSA-N 0.000 claims 1
- ZAUHBHKVJLARKS-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[4-fluoro-2-(trifluoromethyl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=C(C=C(C=C1)F)C(F)(F)F)F ZAUHBHKVJLARKS-UHFFFAOYSA-N 0.000 claims 1
- ASQHHQRJEFZFBH-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-[4-fluoro-3-(trifluoromethyl)phenyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC(=C(C=C1)F)C(F)(F)F)F ASQHHQRJEFZFBH-UHFFFAOYSA-N 0.000 claims 1
- QXOUAOPCYZFXSY-UHFFFAOYSA-N 6-[3-(2,2-difluoroethyl)-5-phenylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=CC=C1)F QXOUAOPCYZFXSY-UHFFFAOYSA-N 0.000 claims 1
- QDTOLPNMVRYFJM-UHFFFAOYSA-N 6-[3-(2,2-difluoropropyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)(C)F QDTOLPNMVRYFJM-UHFFFAOYSA-N 0.000 claims 1
- SIZBLFUPLWZTQX-UHFFFAOYSA-N 6-[3-(2,2-difluoropropyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)(C)F SIZBLFUPLWZTQX-UHFFFAOYSA-N 0.000 claims 1
- YLKNDQZCDDMKFS-UHFFFAOYSA-N 6-[3-(2-cyanoethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(#N)CCN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F YLKNDQZCDDMKFS-UHFFFAOYSA-N 0.000 claims 1
- VZGCNLPPVHROIA-UHFFFAOYSA-N 6-[3-(2-ethoxyethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound C(C)OCCN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F VZGCNLPPVHROIA-UHFFFAOYSA-N 0.000 claims 1
- WXWBBGDDJDOICH-UHFFFAOYSA-N 6-[3-(2-ethoxyethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C(C)OCCN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F WXWBBGDDJDOICH-UHFFFAOYSA-N 0.000 claims 1
- DCZWNLFBLYYQNX-UHFFFAOYSA-N 6-[3-(2-fluoro-2-methylpropyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)(C)C DCZWNLFBLYYQNX-UHFFFAOYSA-N 0.000 claims 1
- WZSHKAWTTZBHSJ-UHFFFAOYSA-N 6-[3-(2-fluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FCCN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F WZSHKAWTTZBHSJ-UHFFFAOYSA-N 0.000 claims 1
- JROMBIFYSBBFAD-UHFFFAOYSA-N 6-[3-(3,3-difluorocyclobutyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1(CC(C1)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)F JROMBIFYSBBFAD-UHFFFAOYSA-N 0.000 claims 1
- RIWSEGDZVLXSMH-UHFFFAOYSA-N 6-[3-(3,3-difluorocyclobutyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1(CC(C1)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)F RIWSEGDZVLXSMH-UHFFFAOYSA-N 0.000 claims 1
- FKAOOXULXXUYOX-UHFFFAOYSA-N 6-[3-(3,3-difluorocyclobutyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1(CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)F FKAOOXULXXUYOX-UHFFFAOYSA-N 0.000 claims 1
- WOMZZCJDUYXJSU-UHFFFAOYSA-N 6-[3-(3,3-difluorocyclopentyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1(CC(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)F WOMZZCJDUYXJSU-UHFFFAOYSA-N 0.000 claims 1
- RFYREBLBAKCPTO-UHFFFAOYSA-N 6-[3-(3,3-difluorocyclopentyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1(CC(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)F RFYREBLBAKCPTO-UHFFFAOYSA-N 0.000 claims 1
- FSAGRQILJJYGPQ-UHFFFAOYSA-N 6-[3-(3,3-difluoropropyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC(CCN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)F FSAGRQILJJYGPQ-UHFFFAOYSA-N 0.000 claims 1
- YKSKNYAJSUCLEI-UHFFFAOYSA-N 6-[3-(3-fluorocyclobutyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F YKSKNYAJSUCLEI-UHFFFAOYSA-N 0.000 claims 1
- PMMAAWSCQNGEHO-UHFFFAOYSA-N 6-[3-(3-fluorocyclobutyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F PMMAAWSCQNGEHO-UHFFFAOYSA-N 0.000 claims 1
- RMPYIDCKQIUJDI-UHFFFAOYSA-N 6-[3-(4,4-difluorocyclohexyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1(CCC(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)F RMPYIDCKQIUJDI-UHFFFAOYSA-N 0.000 claims 1
- WVQLPBGPRVQXFC-UHFFFAOYSA-N 6-[3-(4,4-difluorocyclohexyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1(CCC(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)F WVQLPBGPRVQXFC-UHFFFAOYSA-N 0.000 claims 1
- RFMNWLFXIVNYKM-UHFFFAOYSA-N 6-[3-(azetidin-3-yl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound N1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F RFMNWLFXIVNYKM-UHFFFAOYSA-N 0.000 claims 1
- CUDDPXAPYOQMDE-UHFFFAOYSA-N 6-[3-(azetidin-3-yl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound N1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F CUDDPXAPYOQMDE-UHFFFAOYSA-N 0.000 claims 1
- KTBVMIBZFUFNME-QGZVFWFLSA-N 6-[3-[(2R)-2,3-dihydroxypropyl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound O[C@H](CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F)CO KTBVMIBZFUFNME-QGZVFWFLSA-N 0.000 claims 1
- NWABDLHJRXAOMN-OAHLLOKOSA-N 6-[3-[(2R)-2,3-dihydroxypropyl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound O[C@H](CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)CO NWABDLHJRXAOMN-OAHLLOKOSA-N 0.000 claims 1
- NWABDLHJRXAOMN-HNNXBMFYSA-N 6-[3-[(2S)-2,3-dihydroxypropyl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound O[C@@H](CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)CO NWABDLHJRXAOMN-HNNXBMFYSA-N 0.000 claims 1
- ASUHHNXCGIKMMM-UHFFFAOYSA-N 6-[3-[1-(cyanomethyl)azetidin-3-yl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(#N)CN1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F ASUHHNXCGIKMMM-UHFFFAOYSA-N 0.000 claims 1
- LTWJOYWIYVWIRU-UHFFFAOYSA-N 6-[3-[1-(difluoromethyl)cyclopropyl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine Chemical compound FC(C1(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C=CN=2)C1=CC=C(C=C1)F)F LTWJOYWIYVWIRU-UHFFFAOYSA-N 0.000 claims 1
- AJQMVODYPDSYHC-UHFFFAOYSA-N 6-[3-[1-(tert-butylcarbamoyl)azetidin-3-yl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C(C)(C)(C)NC(=O)N1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F AJQMVODYPDSYHC-UHFFFAOYSA-N 0.000 claims 1
- QGYMFQQNRNNHQD-UHFFFAOYSA-N 6-[3-[3-(dimethylamino)propyl]-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound CN(CCCN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F)C QGYMFQQNRNNHQD-UHFFFAOYSA-N 0.000 claims 1
- NCKWQOANBSQJHV-UHFFFAOYSA-N 6-[3-butan-2-yl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound C(C)(CC)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F NCKWQOANBSQJHV-UHFFFAOYSA-N 0.000 claims 1
- JIALVLIWDWZWDG-UHFFFAOYSA-N 6-[3-butan-2-yl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C(C)(CC)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F JIALVLIWDWZWDG-UHFFFAOYSA-N 0.000 claims 1
- QGHWZIKIOMMRND-UHFFFAOYSA-N 6-[3-cyclobutyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound C1(CCC1)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1=CC=C(C=C1)F QGHWZIKIOMMRND-UHFFFAOYSA-N 0.000 claims 1
- FTCVMGYNDFLVEU-UHFFFAOYSA-N 6-[3-cyclobutyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C1(CCC1)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F FTCVMGYNDFLVEU-UHFFFAOYSA-N 0.000 claims 1
- AIYRFVWYJVVINZ-UHFFFAOYSA-N 6-[3-cyclopentyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C1(CCCC1)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F AIYRFVWYJVVINZ-UHFFFAOYSA-N 0.000 claims 1
- PGFAFHKJWYBPRA-UHFFFAOYSA-N 6-[3-cyclopropyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C1(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F PGFAFHKJWYBPRA-UHFFFAOYSA-N 0.000 claims 1
- QUSKVWVKMWZCPM-UHFFFAOYSA-N 6-[3-cyclopropyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C1(CC1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F QUSKVWVKMWZCPM-UHFFFAOYSA-N 0.000 claims 1
- XZKZICVQVAPDDY-UHFFFAOYSA-N 6-[3-ethyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C(C)N1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F XZKZICVQVAPDDY-UHFFFAOYSA-N 0.000 claims 1
- FOWRMRUKQMVYKL-UHFFFAOYSA-N 6-[3-ethyl-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C(C)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1=CC=C(C=C1)F FOWRMRUKQMVYKL-UHFFFAOYSA-N 0.000 claims 1
- MSGJWFDTRJCLLR-UHFFFAOYSA-N 6-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]-1,3-benzothiazole Chemical compound CN1C=NC(=C1C1=CC2=C(N=CS2)C=C1)C=1C=C(C=CC=1)C MSGJWFDTRJCLLR-UHFFFAOYSA-N 0.000 claims 1
- KTXPOBFCSXNKQI-UHFFFAOYSA-N 6-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound CN1C=NC(=C1C=1C=CC=2N(C=1)C=CN=2)C=1C=C(C=CC=1)C KTXPOBFCSXNKQI-UHFFFAOYSA-N 0.000 claims 1
- RJXDSJNMVAKKOP-UHFFFAOYSA-N 6-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]quinoline Chemical compound CN1C=NC(=C1C=1C=C2C=CC=NC2=CC=1)C=1C=C(C=CC=1)C RJXDSJNMVAKKOP-UHFFFAOYSA-N 0.000 claims 1
- SNXRXCQPTDGMAZ-UHFFFAOYSA-N 6-[3-methyl-5-(3-methylphenyl)imidazol-4-yl]quinoxaline Chemical compound CN1C=NC(=C1C=1C=C2N=CC=NC2=CC=1)C=1C=C(C=CC=1)C SNXRXCQPTDGMAZ-UHFFFAOYSA-N 0.000 claims 1
- IZQQYOFLBGQASQ-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-1H-imidazol-5-yl]quinoline Chemical compound FC=1C=C(C=CC=1F)C=1N=CNC=1C=1C=C2C=CC=NC2=CC=1 IZQQYOFLBGQASQ-UHFFFAOYSA-N 0.000 claims 1
- JKLHNDTYBAVKFD-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-ethyl-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)CC JKLHNDTYBAVKFD-UHFFFAOYSA-N 0.000 claims 1
- OMUULXNVEBKCHL-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-ethyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C1=CC=C2C=NNC2=C1)CC OMUULXNVEBKCHL-UHFFFAOYSA-N 0.000 claims 1
- RTAVNGIVSJLIST-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-ethyl-1H-imidazol-5-yl]quinoxaline Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=C2N=CC=NC2=CC=1)CC RTAVNGIVSJLIST-UHFFFAOYSA-N 0.000 claims 1
- CJNWKJNDTBDYPX-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)C CJNWKJNDTBDYPX-UHFFFAOYSA-N 0.000 claims 1
- KDGQOWDDBPDDNT-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl]-1-methylbenzimidazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=CC2=C(N(C=N2)C)C=1)C KDGQOWDDBPDDNT-UHFFFAOYSA-N 0.000 claims 1
- JUAKDQMJFVEJOZ-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C1=CC=C2C=NNC2=C1)C JUAKDQMJFVEJOZ-UHFFFAOYSA-N 0.000 claims 1
- IYQQGABGRYKKMK-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl]quinoline Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=C2C=CC=NC2=CC=1)C IYQQGABGRYKKMK-UHFFFAOYSA-N 0.000 claims 1
- UQTISQJKNZTUFQ-UHFFFAOYSA-N 6-[4-(3,4-difluorophenyl)-2-methyl-1H-imidazol-5-yl]quinoxaline Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=C2N=CC=NC2=CC=1)C UQTISQJKNZTUFQ-UHFFFAOYSA-N 0.000 claims 1
- NLESOCGLJAHTCF-UHFFFAOYSA-N 6-[4-(3,5-difluorophenyl)-2-ethyl-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound FC=1C=C(C=C(C=1)F)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)CC NLESOCGLJAHTCF-UHFFFAOYSA-N 0.000 claims 1
- YJHCGVRDEIJRQD-UHFFFAOYSA-N 6-[4-(3-chloro-5-fluorophenyl)-2-ethyl-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound ClC=1C=C(C=C(C=1)F)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)CC YJHCGVRDEIJRQD-UHFFFAOYSA-N 0.000 claims 1
- GBZLEIHHETZMDT-UHFFFAOYSA-N 6-[4-(3-chloro-5-fluorophenyl)-2-ethyl-1H-imidazol-5-yl]quinoxaline Chemical compound ClC=1C=C(C=C(C=1)F)C=1N=C(NC=1C=1C=C2N=CC=NC2=CC=1)CC GBZLEIHHETZMDT-UHFFFAOYSA-N 0.000 claims 1
- FUTZMMVVSZGXRV-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-1,3-thiazol-5-yl]-1,3-benzothiazole Chemical compound ClC=1C=C(C=CC=1)C=1N=CSC=1C1=CC2=C(N=CS2)C=C1 FUTZMMVVSZGXRV-UHFFFAOYSA-N 0.000 claims 1
- LIPGJGPPZAVKDI-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-1H-imidazol-5-yl]quinoline Chemical compound ClC=1C=C(C=CC=1)C=1N=CNC=1C=1C=C2C=CC=NC2=CC=1 LIPGJGPPZAVKDI-UHFFFAOYSA-N 0.000 claims 1
- FRLWWQDTYQUAQB-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-2-ethyl-1H-imidazol-5-yl]quinoline Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=C2C=CC=NC2=CC=1)CC FRLWWQDTYQUAQB-UHFFFAOYSA-N 0.000 claims 1
- PLSSMUKKJNCZSS-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-2-ethyl-1H-imidazol-5-yl]quinoxaline Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=C2N=CC=NC2=CC=1)CC PLSSMUKKJNCZSS-UHFFFAOYSA-N 0.000 claims 1
- UFWWTBXPJRUJSU-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)-2-methyl-1H-imidazol-5-yl]quinoline Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=C2C=CC=NC2=CC=1)C UFWWTBXPJRUJSU-UHFFFAOYSA-N 0.000 claims 1
- FKJUHKDKVKXASE-UHFFFAOYSA-N 6-[4-(3-fluorophenyl)-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound FC=1C=C(C=CC=1)C=1N=CNC=1C1=CC2=C(N=CS2)C=C1 FKJUHKDKVKXASE-UHFFFAOYSA-N 0.000 claims 1
- RWNBDUOLQZJVRG-UHFFFAOYSA-N 6-[4-(3-fluorophenyl)-1H-imidazol-5-yl]-1-methylbenzimidazole Chemical compound FC=1C=C(C=CC=1)C=1N=CNC=1C=1C=CC2=C(N(C=N2)C)C=1 RWNBDUOLQZJVRG-UHFFFAOYSA-N 0.000 claims 1
- KCLXUMNTQBONIZ-UHFFFAOYSA-N 6-[4-(3-fluorophenyl)-1H-imidazol-5-yl]-1H-quinolin-2-one Chemical compound FC=1C=C(C=CC=1)C=1N=CNC=1C=1C=C2C=CC(NC2=CC=1)=O KCLXUMNTQBONIZ-UHFFFAOYSA-N 0.000 claims 1
- QHKXNCROKJBHDD-UHFFFAOYSA-N 6-[4-(3-methylphenyl)-1,3-thiazol-5-yl]-1,3-benzothiazole Chemical compound C1(=CC(=CC=C1)C=1N=CSC=1C1=CC2=C(N=CS2)C=C1)C QHKXNCROKJBHDD-UHFFFAOYSA-N 0.000 claims 1
- NXEDKPHFWIKNSO-UHFFFAOYSA-N 6-[4-(3-methylphenyl)-1H-imidazol-5-yl]quinoxaline Chemical compound C1(=CC(=CC=C1)C=1N=CNC=1C=1C=C2N=CC=NC2=CC=1)C NXEDKPHFWIKNSO-UHFFFAOYSA-N 0.000 claims 1
- PYFXCZXDKRTMMD-UHFFFAOYSA-N 6-[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-5-yl]-1,3-benzothiazole Chemical compound FC1=C(C=C(C=C1)C=1N=CSC=1C1=CC2=C(N=CS2)C=C1)C PYFXCZXDKRTMMD-UHFFFAOYSA-N 0.000 claims 1
- MIZNWRKYNXBLJG-UHFFFAOYSA-N 6-[4-(4-fluoro-3-methylphenyl)-2-methyl-1H-imidazol-5-yl]-1,3-benzothiazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)C)C MIZNWRKYNXBLJG-UHFFFAOYSA-N 0.000 claims 1
- ZDFZDFPXFGMBNG-UHFFFAOYSA-N 6-[4-(4-fluoro-3-methylphenyl)-2-methyl-1H-imidazol-5-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(NC=1C1=CC=C2C=NNC2=C1)C)C ZDFZDFPXFGMBNG-UHFFFAOYSA-N 0.000 claims 1
- MUNPLTCTZPWFJO-UHFFFAOYSA-N 6-[4-(4-fluoro-3-methylphenyl)-2-methyl-1H-imidazol-5-yl]quinoline Chemical compound FC1=C(C=C(C=C1)C=1N=C(NC=1C=1C=C2C=CC=NC2=CC=1)C)C MUNPLTCTZPWFJO-UHFFFAOYSA-N 0.000 claims 1
- FIFYPAGKPOECPS-UHFFFAOYSA-N 6-[4-(4-fluoro-3-methylphenyl)-2-methyl-1H-imidazol-5-yl]quinoxaline Chemical compound FC1=C(C=C(C=C1)C=1N=C(NC=1C=1C=C2N=CC=NC2=CC=1)C)C FIFYPAGKPOECPS-UHFFFAOYSA-N 0.000 claims 1
- LMIVBCCKJVUCHC-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)-1,3-thiazol-5-yl]-1,3-benzothiazole Chemical compound FC1=CC=C(C=C1)C=1N=CSC=1C1=CC2=C(N=CS2)C=C1 LMIVBCCKJVUCHC-UHFFFAOYSA-N 0.000 claims 1
- PZIQLFMLKWWUIR-UHFFFAOYSA-N 6-[5-(1,3-benzodioxol-5-yl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound O1COC2=C1C=CC(=C2)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F PZIQLFMLKWWUIR-UHFFFAOYSA-N 0.000 claims 1
- IDZKZOVWKKCQCH-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC=1C=C(C=CC=1F)C=1N=CNC=1C=1C=CC=2N(C=1)C=CN=2 IDZKZOVWKKCQCH-UHFFFAOYSA-N 0.000 claims 1
- LZGRBPSSJPCSBJ-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-2-ethyl-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=CC=2N(C=1)N=CN=2)CC LZGRBPSSJPCSBJ-UHFFFAOYSA-N 0.000 claims 1
- MTFOWDJVCJVNGB-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-2-ethyl-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=CC=2N(C=1)C=CN=2)CC MTFOWDJVCJVNGB-UHFFFAOYSA-N 0.000 claims 1
- VGSCURRVZNJGJG-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-2-methyl-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC=1C=C(C=CC=1F)C=1N=C(NC=1C=1C=CC=2N(C=1)C=CN=2)C VGSCURRVZNJGJG-UHFFFAOYSA-N 0.000 claims 1
- AFAVPIKICHICBI-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-3-methylimidazol-4-yl]-1,3-benzothiazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CN(C=1C1=CC2=C(N=CS2)C=C1)C AFAVPIKICHICBI-UHFFFAOYSA-N 0.000 claims 1
- ADXIHGMROQTHLI-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-3-methylimidazol-4-yl]-1-methylbenzimidazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC2=C(N(C=N2)C)C=1)C ADXIHGMROQTHLI-UHFFFAOYSA-N 0.000 claims 1
- JUKOCLMKRKHWBX-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound FC=1C=C(C=CC=1F)C=1N=CN(C=1C1=CC=C2C=NNC2=C1)C JUKOCLMKRKHWBX-UHFFFAOYSA-N 0.000 claims 1
- GPVZGUBMDVNESX-UHFFFAOYSA-N 6-[5-(3,4-difluorophenyl)-3-methylimidazol-4-yl]quinoxaline Chemical compound FC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=C2N=CC=NC2=CC=1)C GPVZGUBMDVNESX-UHFFFAOYSA-N 0.000 claims 1
- IOHDAPPOSVPWTE-UHFFFAOYSA-N 6-[5-(3,5-dichlorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=C(C=1)Cl)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F IOHDAPPOSVPWTE-UHFFFAOYSA-N 0.000 claims 1
- TWLZNDMBGXEJBX-UHFFFAOYSA-N 6-[5-(3-aminophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound NC=1C=C(C=CC=1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F TWLZNDMBGXEJBX-UHFFFAOYSA-N 0.000 claims 1
- KUXJINJKQXVKIZ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(1,3-dihydroxypropan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C(CO)CO KUXJINJKQXVKIZ-UHFFFAOYSA-N 0.000 claims 1
- LILHDFQTAZTSON-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(1-methylcyclopropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1(CC1)C LILHDFQTAZTSON-UHFFFAOYSA-N 0.000 claims 1
- YVNKXHMNLKUJSE-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC(F)F YVNKXHMNLKUJSE-UHFFFAOYSA-N 0.000 claims 1
- LKMUHOZQCOCZFO-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CC(F)F LKMUHOZQCOCZFO-UHFFFAOYSA-N 0.000 claims 1
- ADISVDWZMXKXRY-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F ADISVDWZMXKXRY-UHFFFAOYSA-N 0.000 claims 1
- QBYUNCUYSNVTQA-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CC(F)F QBYUNCUYSNVTQA-UHFFFAOYSA-N 0.000 claims 1
- OZQIGEIDLNUENK-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2,2-difluoropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(C)(F)F OZQIGEIDLNUENK-UHFFFAOYSA-N 0.000 claims 1
- XVOPIACIPAWDDD-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2,2-difluoropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CC(C)(F)F XVOPIACIPAWDDD-UHFFFAOYSA-N 0.000 claims 1
- FIOBJKSXFZLAEG-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-cyclobutylethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCC1CCC1 FIOBJKSXFZLAEG-UHFFFAOYSA-N 0.000 claims 1
- QXZLJNTZLYUGPG-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-cyclobutylethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCC1CCC1 QXZLJNTZLYUGPG-UHFFFAOYSA-N 0.000 claims 1
- HYBHAOUMMFCVRW-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-fluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C=CN=2)CCF HYBHAOUMMFCVRW-UHFFFAOYSA-N 0.000 claims 1
- XOIYOIGNSNYANK-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-fluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCF XOIYOIGNSNYANK-UHFFFAOYSA-N 0.000 claims 1
- DNTPIIWPTVEHQK-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-fluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCF DNTPIIWPTVEHQK-UHFFFAOYSA-N 0.000 claims 1
- WPQKUQNZUWSTBF-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-hydroxyethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CCO WPQKUQNZUWSTBF-UHFFFAOYSA-N 0.000 claims 1
- LLLXKQQRQMABHI-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-methoxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCOC LLLXKQQRQMABHI-UHFFFAOYSA-N 0.000 claims 1
- NGYILYGTZDVRJX-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-methoxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCOC NGYILYGTZDVRJX-UHFFFAOYSA-N 0.000 claims 1
- UNGWVMLWLOGONB-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-morpholin-4-ylethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CCN1CCOCC1 UNGWVMLWLOGONB-UHFFFAOYSA-N 0.000 claims 1
- XDHCKUDABKHAOU-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-morpholin-4-ylethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CCN1CCOCC1 XDHCKUDABKHAOU-UHFFFAOYSA-N 0.000 claims 1
- VXKHGTXUOXLAIN-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(2-pyrrolidin-1-ylethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCN1CCCC1 VXKHGTXUOXLAIN-UHFFFAOYSA-N 0.000 claims 1
- IIIMXPQVWJYNSJ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3,3-trifluoro-2-hydroxypropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(C(F)(F)F)O IIIMXPQVWJYNSJ-UHFFFAOYSA-N 0.000 claims 1
- HWFYDNNLLUQNOJ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3,3-trifluoropropyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C=CN=2)CCC(F)(F)F HWFYDNNLLUQNOJ-UHFFFAOYSA-N 0.000 claims 1
- DXZHBNLOGLQUKV-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3,3-trifluoropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCC(F)(F)F DXZHBNLOGLQUKV-UHFFFAOYSA-N 0.000 claims 1
- QKPSZQJOMYEZEF-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3-difluorocyclobutyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C=CN=2)C1CC(C1)(F)F QKPSZQJOMYEZEF-UHFFFAOYSA-N 0.000 claims 1
- FESQNPNRTHYHJI-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3-difluorocyclobutyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1CC(C1)(F)F FESQNPNRTHYHJI-UHFFFAOYSA-N 0.000 claims 1
- ZIZAEJSSNOQTAF-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3-difluorocyclobutyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C1CC(C1)(F)F ZIZAEJSSNOQTAF-UHFFFAOYSA-N 0.000 claims 1
- HTXSUFFVWBZJRM-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3-difluorocyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1CC(C1)(F)F HTXSUFFVWBZJRM-UHFFFAOYSA-N 0.000 claims 1
- OCQMRJZFJKKIEQ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3,3-difluorocyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1CC(C1)(F)F OCQMRJZFJKKIEQ-UHFFFAOYSA-N 0.000 claims 1
- MFVSMRJCPGKLEV-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-chloropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCCCl MFVSMRJCPGKLEV-UHFFFAOYSA-N 0.000 claims 1
- ZMDOBAWHLDFIAT-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-chloropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCCCl ZMDOBAWHLDFIAT-UHFFFAOYSA-N 0.000 claims 1
- QTSUEIBSKWPOLS-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-fluorocyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1CC(C1)F QTSUEIBSKWPOLS-UHFFFAOYSA-N 0.000 claims 1
- UVGRBTYDBOHOBH-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-fluorocyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1CC(C1)F UVGRBTYDBOHOBH-UHFFFAOYSA-N 0.000 claims 1
- VZAYVLRWDPDMQI-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-fluoropropyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C=CN=2)CCCF VZAYVLRWDPDMQI-UHFFFAOYSA-N 0.000 claims 1
- NRJLDSXLNZFWIE-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-fluoropropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CCCF NRJLDSXLNZFWIE-UHFFFAOYSA-N 0.000 claims 1
- WPPDKPCNSUZWST-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-fluoropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCCF WPPDKPCNSUZWST-UHFFFAOYSA-N 0.000 claims 1
- VMOZWAPOMVVQNL-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-hydroxy-3-methylbutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCC(C)(C)O VMOZWAPOMVVQNL-UHFFFAOYSA-N 0.000 claims 1
- DYXLECUXCTUBKW-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-hydroxy-3-methylbutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCC(C)(C)O DYXLECUXCTUBKW-UHFFFAOYSA-N 0.000 claims 1
- OJNNUDOOADABHK-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-hydroxycyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound OC1CC(C1)n1cnc(c1-c1ccc2ncc(C#N)n2n1)-c1ccc(F)c(Cl)c1 OJNNUDOOADABHK-UHFFFAOYSA-N 0.000 claims 1
- LMDNOBRZXKYAJO-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-hydroxycyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound NC(=O)C1=CN=C2C=CC(=NN12)C1=C(N=CN1C1CC(O)C1)C1=CC(Cl)=C(F)C=C1 LMDNOBRZXKYAJO-UHFFFAOYSA-N 0.000 claims 1
- UHKKBSIHLQQAIZ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-hydroxypropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCCO UHKKBSIHLQQAIZ-UHFFFAOYSA-N 0.000 claims 1
- RMCAQQLJZBBHNC-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-hydroxypropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCCO RMCAQQLJZBBHNC-UHFFFAOYSA-N 0.000 claims 1
- SFLZBXWFQIUYDW-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-methylbutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCC(C)C SFLZBXWFQIUYDW-UHFFFAOYSA-N 0.000 claims 1
- CZFFYMSCWHRWSX-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(3-methylbutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCC(C)C CZFFYMSCWHRWSX-UHFFFAOYSA-N 0.000 claims 1
- RENXLJADBBNMNT-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(cyclopropylmethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC1CC1 RENXLJADBBNMNT-UHFFFAOYSA-N 0.000 claims 1
- STGOOMJSVBXASI-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(oxan-4-yl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1CCOCC1 STGOOMJSVBXASI-UHFFFAOYSA-N 0.000 claims 1
- FXROKGQORPAIOA-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(oxan-4-yl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1CCOCC1 FXROKGQORPAIOA-UHFFFAOYSA-N 0.000 claims 1
- ZJJSFBKXYONUAZ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(oxetan-3-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C1COC1 ZJJSFBKXYONUAZ-UHFFFAOYSA-N 0.000 claims 1
- GTIGEBXKUDMQFQ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(oxolan-3-yl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1COCC1 GTIGEBXKUDMQFQ-UHFFFAOYSA-N 0.000 claims 1
- ZUYQOBUZSLINNC-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-(oxolan-3-yl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C1COCC1 ZUYQOBUZSLINNC-UHFFFAOYSA-N 0.000 claims 1
- LUABADMUPNRBMU-CYBMUJFWSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-[(1R)-3,3-difluorocyclopentyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)[C@H]1CC(CC1)(F)F LUABADMUPNRBMU-CYBMUJFWSA-N 0.000 claims 1
- LUABADMUPNRBMU-ZDUSSCGKSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-[(1S)-3,3-difluorocyclopentyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)[C@@H]1CC(CC1)(F)F LUABADMUPNRBMU-ZDUSSCGKSA-N 0.000 claims 1
- NBESPYDHKUMOPU-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-[(3-methyloxetan-3-yl)methyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC1(COC1)C NBESPYDHKUMOPU-UHFFFAOYSA-N 0.000 claims 1
- MHGUMGVQKLZIQO-HNNXBMFYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-[[(2S)-oxolan-2-yl]methyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C[C@H]1OCCC1 MHGUMGVQKLZIQO-HNNXBMFYSA-N 0.000 claims 1
- OMCIPLIDWUIPIN-ZDUSSCGKSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-[[(2S)-oxolan-2-yl]methyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C[C@H]1OCCC1 OMCIPLIDWUIPIN-ZDUSSCGKSA-N 0.000 claims 1
- ZQVPJXVFYKTSBN-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-cyclobutylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1CCC1 ZQVPJXVFYKTSBN-UHFFFAOYSA-N 0.000 claims 1
- FUGMXBFMCSXKJK-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-cyclopropylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1CC1 FUGMXBFMCSXKJK-UHFFFAOYSA-N 0.000 claims 1
- RZFLWYVZRRPMMI-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-ethylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC RZFLWYVZRRPMMI-UHFFFAOYSA-N 0.000 claims 1
- MYDJTAPNMLCPEA-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-ethylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CC MYDJTAPNMLCPEA-UHFFFAOYSA-N 0.000 claims 1
- DUHXTKXHTCXORJ-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-ethylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC DUHXTKXHTCXORJ-UHFFFAOYSA-N 0.000 claims 1
- DDYHDWTZPPIKCF-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-ethylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CC DDYHDWTZPPIKCF-UHFFFAOYSA-N 0.000 claims 1
- WLLUMONZETYRQL-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-methylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C WLLUMONZETYRQL-UHFFFAOYSA-N 0.000 claims 1
- TVUYXGFUVAMUJL-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-methylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C TVUYXGFUVAMUJL-UHFFFAOYSA-N 0.000 claims 1
- GPNGJZBLLOELBK-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C(C)C GPNGJZBLLOELBK-UHFFFAOYSA-N 0.000 claims 1
- YMRMXDIZYJCIPL-UHFFFAOYSA-N 6-[5-(3-chloro-4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound ClC=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C(C)C YMRMXDIZYJCIPL-UHFFFAOYSA-N 0.000 claims 1
- RBADYKVTVNOROH-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1)C=1N=CNC=1C=1C=CC=2N(C=1)C=CN=2 RBADYKVTVNOROH-UHFFFAOYSA-N 0.000 claims 1
- UFQMMVNTOCOUBI-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=CC=2N(C=1)N=CN=2)C(F)(F)F UFQMMVNTOCOUBI-UHFFFAOYSA-N 0.000 claims 1
- QKSYISHZIPRWII-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-2-ethyl-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=CC=2N(C=1)C=CN=2)CC QKSYISHZIPRWII-UHFFFAOYSA-N 0.000 claims 1
- CGZGYTJRBFJNBI-UHFFFAOYSA-N 6-[5-(3-chlorophenyl)-2-methyl-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound ClC=1C=C(C=CC=1)C=1N=C(NC=1C=1C=CC=2N(C=1)N=CN=2)C CGZGYTJRBFJNBI-UHFFFAOYSA-N 0.000 claims 1
- CMMIZEHBXXNCFI-UHFFFAOYSA-N 6-[5-(3-cyano-4-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(#N)C=1C=C(C=CC=1F)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F CMMIZEHBXXNCFI-UHFFFAOYSA-N 0.000 claims 1
- RGAGYQPBNKIVNY-UHFFFAOYSA-N 6-[5-(3-cyanophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(#N)C=1C=C(C=CC=1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F RGAGYQPBNKIVNY-UHFFFAOYSA-N 0.000 claims 1
- RDYXJVPEUIOVHF-UHFFFAOYSA-N 6-[5-(3-methylphenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound C1(=CC(=CC=C1)C=1N=CNC=1C=1C=CC=2N(C=1)C=CN=2)C RDYXJVPEUIOVHF-UHFFFAOYSA-N 0.000 claims 1
- ZDCBJWLCLAODPQ-UHFFFAOYSA-N 6-[5-(3-methylphenyl)-2-propan-2-yl-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C(C)(C)C=1NC(=C(N=1)C=1C=C(C=CC=1)C)C=1C=CC=2N(C=1)N=CN=2 ZDCBJWLCLAODPQ-UHFFFAOYSA-N 0.000 claims 1
- AHOJTOFZHXDXJV-UHFFFAOYSA-N 6-[5-(4-aminophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound NC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F AHOJTOFZHXDXJV-UHFFFAOYSA-N 0.000 claims 1
- HYNPKRWWHULQKX-UHFFFAOYSA-N 6-[5-(4-cyanophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound C(#N)C1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(F)F HYNPKRWWHULQKX-UHFFFAOYSA-N 0.000 claims 1
- GSKUEQFEFVNGEJ-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-2,3-dimethylimidazol-4-yl]-1,3-benzothiazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(N(C=1C1=CC2=C(N=CS2)C=C1)C)C)C GSKUEQFEFVNGEJ-UHFFFAOYSA-N 0.000 claims 1
- ILSZHMFRNFEMRQ-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-2,3-dimethylimidazol-4-yl]-1-methylbenzimidazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(N(C=1C=1C=CC2=C(N(C=N2)C)C=1)C)C)C ILSZHMFRNFEMRQ-UHFFFAOYSA-N 0.000 claims 1
- MSRUHLYMQIFTBC-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-2,3-dimethylimidazol-4-yl]-1H-indazole Chemical compound FC1=C(C=C(C=C1)C=1N=C(N(C=1C1=CC=C2C=NNC2=C1)C)C)C MSRUHLYMQIFTBC-UHFFFAOYSA-N 0.000 claims 1
- KTGWPJVQDKRTCN-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-2-methyl-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC1=C(C=C(C=C1)C=1N=C(NC=1C=1C=CC=2N(C=1)C=CN=2)C)C KTGWPJVQDKRTCN-UHFFFAOYSA-N 0.000 claims 1
- WRAXKSLYUQLPQZ-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-3-methylimidazol-4-yl]quinoline Chemical compound FC1=C(C=C(C=C1)C=1N=CN(C=1C=1C=C2C=CC=NC2=CC=1)C)C WRAXKSLYUQLPQZ-UHFFFAOYSA-N 0.000 claims 1
- YUECAVPCYSOPPJ-UHFFFAOYSA-N 6-[5-(4-fluoro-3-methylphenyl)-3-methylimidazol-4-yl]quinoxaline Chemical compound FC1=C(C=C(C=C1)C=1N=CN(C=1C=1C=C2N=CC=NC2=CC=1)C)C YUECAVPCYSOPPJ-UHFFFAOYSA-N 0.000 claims 1
- PFIHRZZWFYEPKI-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-1H-imidazol-4-yl]-1,3-benzothiazole Chemical compound FC1=CC=C(C=C1)C=1N=CNC=1C1=CC2=C(N=CS2)C=C1 PFIHRZZWFYEPKI-UHFFFAOYSA-N 0.000 claims 1
- CODYXOMSGGVBMG-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-1H-imidazol-4-yl]-1-methylbenzimidazole Chemical compound FC1=CC=C(C=C1)C=1N=CNC=1C=1C=CC2=C(N(C=N2)C)C=1 CODYXOMSGGVBMG-UHFFFAOYSA-N 0.000 claims 1
- AHDDDMIMDGHLAL-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC1=CC=C(C=C1)C=1N=CNC=1C=1C=CC=2N(C=1)C=CN=2 AHDDDMIMDGHLAL-UHFFFAOYSA-N 0.000 claims 1
- ZCPQBAGXLCGWJP-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-1H-imidazol-4-yl]quinoline Chemical compound FC1=CC=C(C=C1)C=1N=CNC=1C=1C=C2C=CC=NC2=CC=1 ZCPQBAGXLCGWJP-UHFFFAOYSA-N 0.000 claims 1
- SIHUEOGPUISKES-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-2-(trifluoromethyl)-1H-imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C=1C=CC=2N(C=1)N=CN=2)C(F)(F)F SIHUEOGPUISKES-UHFFFAOYSA-N 0.000 claims 1
- QAZRGZOHBMFOEA-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-2-methyl-1H-imidazol-4-yl]-1,3-benzothiazole Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C1=CC2=C(N=CS2)C=C1)C QAZRGZOHBMFOEA-UHFFFAOYSA-N 0.000 claims 1
- UDKWWDRWWKJTCW-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-2-methyl-1H-imidazol-4-yl]-1-methylbenzimidazole Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C=1C=CC2=C(N(C=N2)C)C=1)C UDKWWDRWWKJTCW-UHFFFAOYSA-N 0.000 claims 1
- MELYHCNOUADKDH-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-2-methyl-1H-imidazol-4-yl]-1H-indazole Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C1=CC=C2C=NNC2=C1)C MELYHCNOUADKDH-UHFFFAOYSA-N 0.000 claims 1
- XEOJPFNWDIWGRB-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-2-methyl-1H-imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C=1C=CC=2N(C=1)C=CN=2)C XEOJPFNWDIWGRB-UHFFFAOYSA-N 0.000 claims 1
- ZBCIFRQXWBGPMC-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-2-methyl-1H-imidazol-4-yl]quinoxaline Chemical compound FC1=CC=C(C=C1)C=1N=C(NC=1C=1C=C2N=CC=NC2=CC=1)C ZBCIFRQXWBGPMC-UHFFFAOYSA-N 0.000 claims 1
- JSFIGRYGSXWRAP-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(1-hydroxybutan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C(CO)CC JSFIGRYGSXWRAP-UHFFFAOYSA-N 0.000 claims 1
- RENRLZJNMMGMGN-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(1-hydroxypropan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C(CO)C RENRLZJNMMGMGN-UHFFFAOYSA-N 0.000 claims 1
- DSRFDWCUVBXTGH-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxy-2-methylpropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC(C)(C)O DSRFDWCUVBXTGH-UHFFFAOYSA-N 0.000 claims 1
- UDKRUJXKJQMKNX-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxy-2-methylpropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CC(C)(C)O UDKRUJXKJQMKNX-UHFFFAOYSA-N 0.000 claims 1
- IYLJVEMAFXLMSQ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxy-2-methylpropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CC(C)(C)O IYLJVEMAFXLMSQ-UHFFFAOYSA-N 0.000 claims 1
- DEJFKKXYWYDRLO-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxybutyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC(CC)O DEJFKKXYWYDRLO-UHFFFAOYSA-N 0.000 claims 1
- AIQZOKCURJAIIL-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCO AIQZOKCURJAIIL-UHFFFAOYSA-N 0.000 claims 1
- ADMFSAZMPDHQIA-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-hydroxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCO ADMFSAZMPDHQIA-UHFFFAOYSA-N 0.000 claims 1
- JIAYODFIBSWOEZ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-methylbutan-2-yl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C(C)(C)CC JIAYODFIBSWOEZ-UHFFFAOYSA-N 0.000 claims 1
- ACNMIECPKONSAC-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-methylpropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC(C)C ACNMIECPKONSAC-UHFFFAOYSA-N 0.000 claims 1
- NWVQODHBLKJPEP-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-methylpropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CC(C)C NWVQODHBLKJPEP-UHFFFAOYSA-N 0.000 claims 1
- DKIXWWZJMRYFGZ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-propan-2-yloxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCOC(C)C DKIXWWZJMRYFGZ-UHFFFAOYSA-N 0.000 claims 1
- SDDPIHXJSFDYMQ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(2-propan-2-yloxyethyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCOC(C)C SDDPIHXJSFDYMQ-UHFFFAOYSA-N 0.000 claims 1
- INIGOXBLEFDAFT-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3,3,3-trifluoro-2-hydroxypropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CC(C(F)(F)F)O INIGOXBLEFDAFT-UHFFFAOYSA-N 0.000 claims 1
- VPJUKXDRFZUCHZ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3,3,3-trifluoropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCC(F)(F)F VPJUKXDRFZUCHZ-UHFFFAOYSA-N 0.000 claims 1
- RFVGGBDNYSLWPR-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-fluoropropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CCCF RFVGGBDNYSLWPR-UHFFFAOYSA-N 0.000 claims 1
- UQDGPXOYCTVOTF-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-fluoropropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CCCF UQDGPXOYCTVOTF-UHFFFAOYSA-N 0.000 claims 1
- VXLVGMOLBXXQNL-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-fluoropropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCCF VXLVGMOLBXXQNL-UHFFFAOYSA-N 0.000 claims 1
- RUFJJHLOWAYYNK-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxy-3-methylbutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCC(C)(C)O RUFJJHLOWAYYNK-UHFFFAOYSA-N 0.000 claims 1
- NGFQAVLDGQLYNQ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxy-3-methylbutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCC(C)(C)O NGFQAVLDGQLYNQ-UHFFFAOYSA-N 0.000 claims 1
- IWTCADQVPWNVNN-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxybutyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CCC(C)O IWTCADQVPWNVNN-UHFFFAOYSA-N 0.000 claims 1
- JYLYCULAGFZEAI-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxybutyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CCC(C)O JYLYCULAGFZEAI-UHFFFAOYSA-N 0.000 claims 1
- GLZOQPSTVWPPIV-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxycyclobutyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound OC1CC(C1)n1cnc(c1-c1ccc2ncc(C#N)n2n1)-c1ccc(F)cc1 GLZOQPSTVWPPIV-UHFFFAOYSA-N 0.000 claims 1
- SSBWXGUNQFOPOM-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CCCO SSBWXGUNQFOPOM-UHFFFAOYSA-N 0.000 claims 1
- TWEBTADDMSZEKL-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CCCO TWEBTADDMSZEKL-UHFFFAOYSA-N 0.000 claims 1
- NVFRRXLVBWBYTQ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)CCCO NVFRRXLVBWBYTQ-UHFFFAOYSA-N 0.000 claims 1
- ZVXZLMXBEZHKDX-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-hydroxypropyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)CCCO ZVXZLMXBEZHKDX-UHFFFAOYSA-N 0.000 claims 1
- HMRNCVXMQXJQIN-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(3-methylbutan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C(C)C(C)C HMRNCVXMQXJQIN-UHFFFAOYSA-N 0.000 claims 1
- XVCPIKKOZXLMPZ-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(4-hydroxybutan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C(C)CCO XVCPIKKOZXLMPZ-UHFFFAOYSA-N 0.000 claims 1
- MRVIYOQDXJTJQN-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(4-hydroxybutan-2-yl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C(C)CCO MRVIYOQDXJTJQN-UHFFFAOYSA-N 0.000 claims 1
- IZRFKGMRSRDVAV-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-(oxetan-3-yl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1COC1 IZRFKGMRSRDVAV-UHFFFAOYSA-N 0.000 claims 1
- QYXUDJJTDANZPN-OAHLLOKOSA-N 6-[5-(4-fluorophenyl)-3-[(2R)-1-hydroxybutan-2-yl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound CC[C@H](CO)n1cnc(c1-c1ccc2ncc(C#N)n2n1)-c1ccc(F)cc1 QYXUDJJTDANZPN-OAHLLOKOSA-N 0.000 claims 1
- NZNHLAFXQJJHMK-CYBMUJFWSA-N 6-[5-(4-fluorophenyl)-3-[(2R)-2-hydroxypropyl]imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C[C@@H](C)O NZNHLAFXQJJHMK-CYBMUJFWSA-N 0.000 claims 1
- PBUPOQJQLZDRPW-GFCCVEGCSA-N 6-[5-(4-fluorophenyl)-3-[(2R)-2-hydroxypropyl]imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C[C@@H](C)O PBUPOQJQLZDRPW-GFCCVEGCSA-N 0.000 claims 1
- PJHMWSSMEQZEOI-CQSZACIVSA-N 6-[5-(4-fluorophenyl)-3-[(2R)-4,4,4-trifluoro-1-hydroxybutan-2-yl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)[C@@H](CO)CC(F)(F)F PJHMWSSMEQZEOI-CQSZACIVSA-N 0.000 claims 1
- NZNHLAFXQJJHMK-ZDUSSCGKSA-N 6-[5-(4-fluorophenyl)-3-[(2S)-2-hydroxypropyl]imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C[C@H](C)O NZNHLAFXQJJHMK-ZDUSSCGKSA-N 0.000 claims 1
- PBUPOQJQLZDRPW-LBPRGKRZSA-N 6-[5-(4-fluorophenyl)-3-[(2S)-2-hydroxypropyl]imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C[C@H](C)O PBUPOQJQLZDRPW-LBPRGKRZSA-N 0.000 claims 1
- PJHMWSSMEQZEOI-AWEZNQCLSA-N 6-[5-(4-fluorophenyl)-3-[(2S)-4,4,4-trifluoro-1-hydroxybutan-2-yl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)[C@H](CO)CC(F)(F)F PJHMWSSMEQZEOI-AWEZNQCLSA-N 0.000 claims 1
- IWZYADDJULNIJB-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-[3-(hydroxymethyl)cyclobutyl]imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1CC(C1)CO IWZYADDJULNIJB-UHFFFAOYSA-N 0.000 claims 1
- GTGVZPXTUCMNPS-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-methylimidazol-4-yl]-1,3-benzothiazole Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C1=CC2=C(N=CS2)C=C1)C GTGVZPXTUCMNPS-UHFFFAOYSA-N 0.000 claims 1
- QSAZNVKUIRFIPK-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-methylimidazol-4-yl]-1-methylbenzimidazole Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC2=C(N(C=N2)C)C=1)C QSAZNVKUIRFIPK-UHFFFAOYSA-N 0.000 claims 1
- DIYPVGPWKNMSSD-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C1=CC=C2C=NNC2=C1)C DIYPVGPWKNMSSD-UHFFFAOYSA-N 0.000 claims 1
- MPJRDTOQAWNWAP-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-methylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C MPJRDTOQAWNWAP-UHFFFAOYSA-N 0.000 claims 1
- ORNNTDFLNDWYJV-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-methylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C ORNNTDFLNDWYJV-UHFFFAOYSA-N 0.000 claims 1
- MJSQBAZIZRVQJM-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-pentan-3-ylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C(CC)CC MJSQBAZIZRVQJM-UHFFFAOYSA-N 0.000 claims 1
- BXQSRQRRUJWZPU-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)C(C)C BXQSRQRRUJWZPU-UHFFFAOYSA-N 0.000 claims 1
- NNGPZCGOODTCBS-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)C(C)C NNGPZCGOODTCBS-UHFFFAOYSA-N 0.000 claims 1
- FLOGFPWWNWYVPN-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carbonitrile Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C#N)C(C)C FLOGFPWWNWYVPN-UHFFFAOYSA-N 0.000 claims 1
- VVWPOXCVDNYFIL-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(N=1)C(=CN=2)C(=O)N)C(C)C VVWPOXCVDNYFIL-UHFFFAOYSA-N 0.000 claims 1
- PHGCMKZBZKQNIH-UHFFFAOYSA-N 6-[5-(4-fluorophenyl)-3-propylimidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC1=CC=C(C=C1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CCC PHGCMKZBZKQNIH-UHFFFAOYSA-N 0.000 claims 1
- MMBBJMTYFPDKQK-UHFFFAOYSA-N 6-[5-(4-methoxyphenyl)-3-methylimidazol-4-yl]-1H-indazole Chemical compound COC1=CC=C(C=C1)C=1N=CN(C=1C1=CC=C2C=NNC2=C1)C MMBBJMTYFPDKQK-UHFFFAOYSA-N 0.000 claims 1
- JLMXSTUHOKPMFG-UHFFFAOYSA-N 6-[5-(5-chloro-2,4-difluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C(=CC(=C(C=1)C=1N=CN(C=1C=1C=CC=2N(C=1)C=CN=2)CC(F)F)F)F JLMXSTUHOKPMFG-UHFFFAOYSA-N 0.000 claims 1
- PBACLGKMTHZPFM-UHFFFAOYSA-N 6-[5-(5-chloro-2-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine Chemical compound ClC=1C=CC(=C(C=1)C=1N=CN(C=1C=1C=CC=2N(C=1)C=CN=2)CC(F)F)F PBACLGKMTHZPFM-UHFFFAOYSA-N 0.000 claims 1
- IDPRNTJHTVGGCA-UHFFFAOYSA-N 6-[5-(5-chloro-2-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carbonitrile Chemical compound ClC=1C=CC(=C(C=1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C#N)CC(F)F)F IDPRNTJHTVGGCA-UHFFFAOYSA-N 0.000 claims 1
- BILHIBRITDUFJS-UHFFFAOYSA-N 6-[5-(5-chloro-2-fluorophenyl)-3-(2,2-difluoroethyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound ClC=1C=CC(=C(C=1)C=1N=CN(C=1C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)CC(F)F)F BILHIBRITDUFJS-UHFFFAOYSA-N 0.000 claims 1
- VHJMTDJWLOCXKK-UHFFFAOYSA-N 6-[7-(2,2-difluoroethyl)-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound FC(CN1CC=2N(CC1)C(=C(N=2)C1=CC=C(C=C1)F)C=1C=CC=2N(C=1)C(=CN=2)C(=O)N)F VHJMTDJWLOCXKK-UHFFFAOYSA-N 0.000 claims 1
- YVYOKWAPEVPPGT-UHFFFAOYSA-N 6-[7-acetyl-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-3-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C(C)(=O)N1CC=2N(CC1)C(=C(N=2)C1=CC=C(C=C1)F)C=1C=CC=2N(C=1)C(=CN=2)C(=O)N YVYOKWAPEVPPGT-UHFFFAOYSA-N 0.000 claims 1
- OBOSTDRRRFCLIH-UHFFFAOYSA-N 7-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(CN1C=NC(=C1C1=CC=2N(C=C1)N=CN=2)C1=CC=C(C=C1)F)F OBOSTDRRRFCLIH-UHFFFAOYSA-N 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- FVHWXGRGNCTEPQ-UHFFFAOYSA-N C(C)N1C=NC(=C1C=1C=CC=2N(C1)C(=CN2)C#N)C2=CC=C(C=C2)F.C2(CCC2)CN2C=NC(=C2C=2C=CC=1N(C2)C(=CN1)C#N)C1=CC=C(C=C1)F Chemical compound C(C)N1C=NC(=C1C=1C=CC=2N(C1)C(=CN2)C#N)C2=CC=C(C=C2)F.C2(CCC2)CN2C=NC(=C2C=2C=CC=1N(C2)C(=CN1)C#N)C1=CC=C(C=C1)F FVHWXGRGNCTEPQ-UHFFFAOYSA-N 0.000 claims 1
- ABUQXVNHOPJKDL-UHFFFAOYSA-N C(C)N1C=NC(=C1C=1C=CC=2N(N1)C(=CN2)C#N)C2=CC=C(C=C2)F.FCCN2C=NC(=C2C=2C=CC=1N(N2)C(=CN1)C#N)C1=CC=C(C=C1)F Chemical compound C(C)N1C=NC(=C1C=1C=CC=2N(N1)C(=CN2)C#N)C2=CC=C(C=C2)F.FCCN2C=NC(=C2C=2C=CC=1N(N2)C(=CN1)C#N)C1=CC=C(C=C1)F ABUQXVNHOPJKDL-UHFFFAOYSA-N 0.000 claims 1
- XPZBNSYWHBKQHI-UHFFFAOYSA-N FC(CN1C(=NC(=C1C=1C=CC=2N(C1)C=CN2)C2=CC=C(C=C2)F)N)F.FC2=CC=C(C=C2)C=2N=C(NC2C=2C=CC=1N(C2)C=CN1)NC(C)=O Chemical compound FC(CN1C(=NC(=C1C=1C=CC=2N(C1)C=CN2)C2=CC=C(C=C2)F)N)F.FC2=CC=C(C=C2)C=2N=C(NC2C=2C=CC=1N(C2)C=CN1)NC(C)=O XPZBNSYWHBKQHI-UHFFFAOYSA-N 0.000 claims 1
- YVCNQWBKZJIGQG-UHFFFAOYSA-N FC1=CC=C(C=C1)C=1N=CNC1C=1C=CC=2N(N1)C(=CN2)C#N.FC2=CC=C(C=C2)C=2N=CN(C2C=2C=CC=1N(N2)C(=CN1)C#N)C1C(CCCC1)O Chemical compound FC1=CC=C(C=C1)C=1N=CNC1C=1C=CC=2N(N1)C(=CN2)C#N.FC2=CC=C(C=C2)C=2N=CN(C2C=2C=CC=1N(N2)C(=CN1)C#N)C1C(CCCC1)O YVCNQWBKZJIGQG-UHFFFAOYSA-N 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 229940124647 MEK inhibitor Drugs 0.000 claims 1
- CVWFXKZMHQPGIN-UHFFFAOYSA-N N-[5-(3-cyanoimidazo[1,2-a]pyridin-6-yl)-1-(2,2-difluoroethyl)-4-(4-fluorophenyl)imidazol-2-yl]acetamide Chemical compound C(#N)C1=CN=C2N1C=C(C=C2)C1=C(N=C(N1CC(F)F)NC(C)=O)C1=CC=C(C=C1)F CVWFXKZMHQPGIN-UHFFFAOYSA-N 0.000 claims 1
- SRUAQXWVXFOEDU-UHFFFAOYSA-N N-[[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridin-3-yl]methyl]-3,3-difluorocyclobutan-1-amine Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)CNC1CC(C1)(F)F)C1=CC=C(C=C1)F)F SRUAQXWVXFOEDU-UHFFFAOYSA-N 0.000 claims 1
- UBWLHHRBKPAYLH-UHFFFAOYSA-N N-[[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]methyl]cyclopropanecarboxamide Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)CNC(=O)C1CC1)C1=CC=C(C=C1)F)F UBWLHHRBKPAYLH-UHFFFAOYSA-N 0.000 claims 1
- DLDAIECUDPBQEV-UHFFFAOYSA-N N-cyclopropyl-6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridine-3-carboxamide Chemical compound C1(CC1)NC(=O)C1=CN=C2N1C=C(C=C2)C1=C(N=CN1CC(F)F)C1=CC=C(C=C1)F DLDAIECUDPBQEV-UHFFFAOYSA-N 0.000 claims 1
- XRWNILSSGPXRRL-UHFFFAOYSA-N N-cyclopropyl-6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C1(CC1)NC(=O)C1=CN=C2N1N=C(C=C2)C1=C(N=CN1CC(F)F)C1=CC=C(C=C1)F XRWNILSSGPXRRL-UHFFFAOYSA-N 0.000 claims 1
- YVLPQHRSYYMYIK-UHFFFAOYSA-N N-tert-butyl-3-[5-(3-cyanoimidazo[1,2-b]pyridazin-6-yl)-4-(4-fluorophenyl)imidazol-1-yl]azetidine-1-carboxamide Chemical compound C(C)(C)(C)NC(=O)N1CC(C1)N1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)C#N)C1=CC=C(C=C1)F YVLPQHRSYYMYIK-UHFFFAOYSA-N 0.000 claims 1
- 239000012270 PD-1 inhibitor Substances 0.000 claims 1
- 239000012668 PD-1-inhibitor Substances 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 206010039580 Scar Diseases 0.000 claims 1
- XHGJZPUFJXDWQS-UHFFFAOYSA-N [6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]methanol Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)CO)C1=CC=C(C=C1)F)F XHGJZPUFJXDWQS-UHFFFAOYSA-N 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 208000013355 benign neoplasm of brain Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- YCLUMBJQKREDFM-UHFFFAOYSA-N imidazo[1,2-b]pyridazine-3-carboxamide Chemical compound C1=CC=NN2C(C(=O)N)=CN=C21 YCLUMBJQKREDFM-UHFFFAOYSA-N 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- ZRINUMCLUXPCSS-UHFFFAOYSA-N methyl 3-(3-carbamoylimidazo[1,2-a]pyridin-6-yl)-2-(4-fluorophenyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate Chemical compound C(N)(=O)C1=CN=C2N1C=C(C=C2)C1=C(N=C2N1CCN(C2)C(=O)OC)C1=CC=C(C=C1)F ZRINUMCLUXPCSS-UHFFFAOYSA-N 0.000 claims 1
- HRDYKDMFKNHRLI-UHFFFAOYSA-N methyl 3-[5-(3-cyanoimidazo[1,2-b]pyridazin-6-yl)-4-(4-fluorophenyl)imidazol-1-yl]azetidine-1-carboxylate Chemical compound C(#N)C1=CN=C2N1N=C(C=C2)C1=C(N=CN1C1CN(C1)C(=O)OC)C1=CC=C(C=C1)F HRDYKDMFKNHRLI-UHFFFAOYSA-N 0.000 claims 1
- QNJMAOVEDIYRQR-UHFFFAOYSA-N methyl N-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-a]pyridin-3-yl]carbamate Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(C=1)C(=CN=2)NC(OC)=O)C1=CC=C(C=C1)F)F QNJMAOVEDIYRQR-UHFFFAOYSA-N 0.000 claims 1
- PETOLPLJUPJGJL-UHFFFAOYSA-N methyl N-[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]carbamate Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)NC(OC)=O)C1=CC=C(C=C1)F)F PETOLPLJUPJGJL-UHFFFAOYSA-N 0.000 claims 1
- GUVLGFQGWDPQJB-UHFFFAOYSA-N methyl N-[[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]methyl]carbamate Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)CNC(OC)=O)C1=CC=C(C=C1)F)F GUVLGFQGWDPQJB-UHFFFAOYSA-N 0.000 claims 1
- 229960003301 nivolumab Drugs 0.000 claims 1
- 229940121655 pd-1 inhibitor Drugs 0.000 claims 1
- KIZAYCDMZCYWOZ-UHFFFAOYSA-N propan-2-yl N-[[6-[3-(2,2-difluoroethyl)-5-(4-fluorophenyl)imidazol-4-yl]imidazo[1,2-b]pyridazin-3-yl]methyl]carbamate Chemical compound FC(CN1C=NC(=C1C=1C=CC=2N(N=1)C(=CN=2)CNC(OC(C)C)=O)C1=CC=C(C=C1)F)F KIZAYCDMZCYWOZ-UHFFFAOYSA-N 0.000 claims 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- BQTCCDHKTZZMLE-UHFFFAOYSA-N tert-butyl 3-[5-(3-carbamoylimidazo[1,2-b]pyridazin-6-yl)-4-(4-fluorophenyl)imidazol-1-yl]azetidine-1-carboxylate Chemical compound C(N)(=O)C1=CN=C2N1N=C(C=C2)C1=C(N=CN1C1CN(C1)C(=O)OC(C)(C)C)C1=CC=C(C=C1)F BQTCCDHKTZZMLE-UHFFFAOYSA-N 0.000 claims 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562127109P | 2015-03-02 | 2015-03-02 | |
| US62/127,109 | 2015-03-02 | ||
| PCT/US2016/019830 WO2016140884A1 (en) | 2015-03-02 | 2016-02-26 | TGF-β INHIBITORS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018510857A JP2018510857A (ja) | 2018-04-19 |
| JP2018510857A5 true JP2018510857A5 (enExample) | 2019-04-04 |
| JP6836998B2 JP6836998B2 (ja) | 2021-03-03 |
Family
ID=55543068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546173A Expired - Fee Related JP6836998B2 (ja) | 2015-03-02 | 2016-02-26 | TGF−β阻害剤 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US9884868B2 (enExample) |
| EP (1) | EP3265454B1 (enExample) |
| JP (1) | JP6836998B2 (enExample) |
| KR (1) | KR20170122799A (enExample) |
| CN (1) | CN107406412B (enExample) |
| AR (1) | AR103828A1 (enExample) |
| AU (1) | AU2016226468B2 (enExample) |
| BR (1) | BR112017017135A2 (enExample) |
| CA (1) | CA2973602A1 (enExample) |
| CL (1) | CL2017002207A1 (enExample) |
| CO (1) | CO2017009891A2 (enExample) |
| EA (1) | EA037112B1 (enExample) |
| ES (1) | ES2789331T3 (enExample) |
| IL (1) | IL254187A0 (enExample) |
| MX (1) | MX371167B (enExample) |
| MY (1) | MY186133A (enExample) |
| PE (1) | PE20171789A1 (enExample) |
| PH (1) | PH12017501326A1 (enExample) |
| SG (1) | SG11201705821XA (enExample) |
| TN (1) | TN2017000374A1 (enExample) |
| TW (1) | TW201639827A (enExample) |
| WO (1) | WO2016140884A1 (enExample) |
| ZA (1) | ZA201705527B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11845745B2 (en) | 2017-03-23 | 2023-12-19 | Clavius Pharmaceuticals, LLC. | Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3265454B1 (en) | 2015-03-02 | 2020-02-26 | Rigel Pharmaceuticals, Inc. | Tgf-beta inhibitors |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| WO2018107072A1 (en) | 2016-12-08 | 2018-06-14 | Board Of Regents, The University Of Texas System | Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease |
| WO2018132279A1 (en) | 2017-01-05 | 2018-07-19 | Bristol-Myers Squibb Company | Tgf beta receptor antagonists |
| WO2018134254A1 (en) | 2017-01-17 | 2018-07-26 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| CN109293652B (zh) * | 2017-07-24 | 2021-10-22 | 四川科伦博泰生物医药股份有限公司 | 一种取代的噻唑衍生物及其用途 |
| GB201718285D0 (en) | 2017-11-03 | 2017-12-20 | Discuva Ltd | Antibacterial Compounds |
| ES2918448T3 (es) | 2018-03-29 | 2022-07-15 | Univ Masarykova | 4-(1H-Imidazol-5-il)-1H-pirrolo [2,3-b]piridinas para su uso en el tratamiento de leucemias, linfomas y tumores sólidos |
| JP7540994B2 (ja) | 2018-07-11 | 2024-08-27 | スカラー ロック インコーポレイテッド | 高親和性のアイソフォーム選択的TGFβ1阻害剤、およびその使用 |
| US12077548B2 (en) | 2018-08-22 | 2024-09-03 | Clavius Pharmaceuticals, LLC. | Substituted imidazoles for the inhibition of TGF-β and methods of treatment |
| CN113195467A (zh) * | 2018-12-11 | 2021-07-30 | 施万生物制药研发Ip有限责任公司 | 适用作alk5抑制剂的萘啶和喹啉衍生物 |
| CN111825658B (zh) * | 2019-04-18 | 2024-11-08 | 华东理工大学 | Egfr三突变抑制剂及其应用 |
| US11560366B2 (en) | 2019-10-21 | 2023-01-24 | Board Of Regents, The University Of Texas System | Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease |
| JP2023502662A (ja) * | 2019-11-22 | 2023-01-25 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | Alk5阻害剤としての置換1,5-ナフチリジンまたはキノリン |
| EP4073102A4 (en) | 2019-12-12 | 2024-05-08 | Ting Therapeutics LLC | Compositions and methods for the prevention and treatment of hearing loss |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| EP4165041A1 (en) * | 2020-06-10 | 2023-04-19 | Theravance Biopharma R&D IP, LLC | Naphthyridine derivatives useful as alk5 inhibitors |
| CN112321592B (zh) * | 2020-11-12 | 2022-03-04 | 山东省科学院菏泽分院 | 一种6-氯咪唑并[1,2-b]哒嗪-3-甲腈的合成方法 |
| WO2022251359A1 (en) * | 2021-05-26 | 2022-12-01 | Theravance Biopharma R&D Ip, Llc | Bicyclic inhibitors of alk5 and methods of use |
| KR20230017756A (ko) * | 2021-07-28 | 2023-02-06 | 주식회사 티움바이오 | 종양 예방 또는 치료용 약학 조성물 및 이의 용도 |
| TW202508595A (zh) | 2023-05-04 | 2025-03-01 | 美商銳新醫藥公司 | 用於ras相關疾病或病症之組合療法 |
| WO2024239186A1 (zh) * | 2023-05-22 | 2024-11-28 | 睿健医药科技(苏州)有限公司 | 吡唑甲酰基哌嗪酮类化合物、药物组合物及其应用 |
| WO2025034702A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Rmc-6291 for use in the treatment of ras protein-related disease or disorder |
| WO2025063820A1 (ko) * | 2023-09-21 | 2025-03-27 | 오토텔릭바이오 주식회사 | 티아졸 유도체 화합물을 포함하는 폐섬유화증 치료용 조성물 |
| WO2025080946A2 (en) | 2023-10-12 | 2025-04-17 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| KR20250144822A (ko) * | 2024-03-27 | 2025-10-13 | 동국대학교 산학협력단 | 신규 옥사졸 유도체 및 이를 포함하는 암 예방 또는 치료용 조성물 |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0008188A (pt) | 1999-01-21 | 2002-02-13 | Metamorphix Inc | Inibidores de fator de diferenciação de crescimento e usos para os mesmos |
| WO2002040468A1 (en) * | 2000-11-16 | 2002-05-23 | Smithkline Beecham Corporation | Compounds |
| CA2440211A1 (en) | 2001-03-09 | 2002-09-19 | Pfizer Products Inc. | Benzimidazole anti-inflammatory compounds |
| US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
| DE60309342T2 (de) | 2002-08-09 | 2007-05-16 | Eli Lilly And Co., Indianapolis | Benzimidazole und benzothiazole als inhibitoren der map-kinase |
| TWI332003B (en) * | 2004-01-30 | 2010-10-21 | Lilly Co Eli | Kinase inhibitors |
| WO2005080380A1 (en) * | 2004-02-03 | 2005-09-01 | Eli Lilly And Company | Kinase inhibitors |
| TWI380996B (zh) | 2004-09-17 | 2013-01-01 | Hoffmann La Roche | 抗ox40l抗體 |
| ES2657443T3 (es) | 2005-03-25 | 2018-03-05 | Gitr, Inc. | Anticuerpos anti-GITR y usos de los mismos |
| AU2006244068B9 (en) | 2005-05-10 | 2012-10-25 | Incyte Holdings Corporation | Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| KR101411165B1 (ko) | 2005-07-01 | 2014-06-25 | 메다렉스, 엘.엘.시. | 예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날항체 |
| US7473784B2 (en) * | 2005-08-01 | 2009-01-06 | Bristol-Myers Squibb Company | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| CA2634198C (en) | 2005-12-20 | 2014-06-03 | Incyte Corporation | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| SI1962830T1 (sl) * | 2005-12-23 | 2013-07-31 | Glaxosmithkline Llc | Azaindolni inhibitorji kinaz Aurora |
| WO2007084391A2 (en) * | 2006-01-18 | 2007-07-26 | Amgen Inc. | Thiazole compounds as protein kinase b ( pkb) inhibitors |
| JP5319532B2 (ja) | 2006-09-19 | 2013-10-16 | インサイト・コーポレイション | インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロサイクル |
| CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
| EP1987839A1 (en) | 2007-04-30 | 2008-11-05 | I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale | Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease |
| WO2008154241A1 (en) * | 2007-06-08 | 2008-12-18 | Abbott Laboratories | 5-heteroaryl substituted indazoles as kinase inhibitors |
| EP2170337A4 (en) * | 2007-06-28 | 2013-12-18 | Abbvie Inc | NEW TRIAZOLOPYRIDAZINE |
| US8591886B2 (en) | 2007-07-12 | 2013-11-26 | Gitr, Inc. | Combination therapies employing GITR binding molecules |
| EP2044949A1 (en) | 2007-10-05 | 2009-04-08 | Immutep | Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| CA2932121A1 (en) | 2007-11-30 | 2009-06-11 | Newlink Genetics Corporation | Ido inhibitors |
| AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
| WO2010077634A1 (en) | 2008-12-09 | 2010-07-08 | Genentech, Inc. | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| CA2772613C (en) | 2009-09-03 | 2020-03-10 | Schering Corporation | Anti-gitr antibodies |
| US8722720B2 (en) | 2009-10-28 | 2014-05-13 | Newlink Genetics Corporation | Imidazole derivatives as IDO inhibitors |
| PL2949670T3 (pl) | 2009-12-10 | 2019-07-31 | F. Hoffmann-La Roche Ag | Przeciwciała wiążące się preferencyjnie z zewnątrzkomórkową domeną 4 ludzkiego CSF-1R i ich zastosowanie |
| US9150656B2 (en) | 2010-03-04 | 2015-10-06 | Macrogenics, Inc. | Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof |
| US9221910B2 (en) | 2010-03-05 | 2015-12-29 | Hoffmann-La Roche Inc. | Antibodies against human CSF-1R |
| US9169323B2 (en) | 2010-03-05 | 2015-10-27 | Hoffmann-La Roche Inc. | Antibodies against human CSF-1R |
| AU2011248083B2 (en) | 2010-05-04 | 2015-09-10 | Five Prime Therapeutics, Inc. | Antibodies that bind CSF1R |
| US8980933B2 (en) * | 2010-05-05 | 2015-03-17 | Universitat Bayreuth | Combretastatin analogs for use in the treatment of cancer |
| MX337040B (es) | 2010-09-09 | 2016-02-09 | Pfizer | Moleculas de union a 4-1bb. |
| AU2011338389A1 (en) | 2010-12-09 | 2013-06-13 | Amgen Inc. | Bicyclic compounds as Pim inhibitors |
| NO2694640T3 (enExample) | 2011-04-15 | 2018-03-17 | ||
| PL2699264T3 (pl) | 2011-04-20 | 2018-08-31 | Medimmune, Llc | Przeciwciała i inne cząsteczki wiążące B7-H1 i PD-1 |
| WO2013007708A1 (en) * | 2011-07-08 | 2013-01-17 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for treatment of liver cancer |
| EP2543372A1 (en) * | 2011-07-08 | 2013-01-09 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for the treatment of liver cancer |
| JP2014525450A (ja) | 2011-09-01 | 2014-09-29 | アイアールエム・リミテッド・ライアビリティ・カンパニー | c−Kitキナーゼ阻害剤としての化合物および組成物 |
| JP6014155B2 (ja) | 2011-10-31 | 2016-10-25 | ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. | ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用 |
| EP2785375B1 (en) | 2011-11-28 | 2020-07-22 | Merck Patent GmbH | Anti-pd-l1 antibodies and uses thereof |
| US9428732B2 (en) * | 2011-12-05 | 2016-08-30 | Primorigen Biosciences, Inc. | Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof |
| TW201329067A (zh) | 2011-12-08 | 2013-07-16 | Amgen Inc | 作為gka活化劑之脲化合物 |
| CA2853889A1 (en) | 2011-12-15 | 2013-06-20 | F. Hoffmann-La Roche Ag | Antibodies against human csf-1r and uses thereof |
| BR112014018961A8 (pt) | 2012-02-06 | 2017-07-11 | Genentech Inc | Anticorpo isolado, anticorpo biespecífico, fragmento, ácido nucleico isolado, vetor, célula hospedeira, método de produção de anticorpos, composição farmacêutica, uso do anticorpo, método de tratamento, método de inibição e artigo industrializado |
| AR090263A1 (es) | 2012-03-08 | 2014-10-29 | Hoffmann La Roche | Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma |
| US10280168B2 (en) | 2012-03-30 | 2019-05-07 | Agency For Science, Technology And Research | Bicyclic heteroaryl derivatives as MNK1 and MNK2 modulators and uses thereof |
| HK1208233A1 (en) | 2012-05-11 | 2016-02-26 | 戊瑞治疗有限公司 | Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r) |
| AR091649A1 (es) | 2012-07-02 | 2015-02-18 | Bristol Myers Squibb Co | Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos |
| EP2890398A4 (en) | 2012-08-31 | 2016-03-09 | Five Prime Therapeutics Inc | METHODS OF TREATING DISEASES WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR RECEIVER 1 (CSF1R) |
| MX2015004151A (es) | 2012-10-05 | 2015-07-06 | Rigel Pharmaceuticals Inc | Inhibidores del factor de diferenciacion de crecimiento-8 (gdf-8). |
| EP2935271B1 (en) * | 2012-12-21 | 2017-10-25 | Bristol-Myers Squibb Company | Novel substituted imidazoles as casein kinase 1 / inhibitors |
| CN103936730A (zh) * | 2013-01-22 | 2014-07-23 | 通化济达医药有限公司 | 苯磺酰胺噻唑激酶抑制剂 |
| CN103275112A (zh) | 2013-05-11 | 2013-09-04 | 济南韶远医药技术有限公司 | 一种利用微反应器连续合成芳基硼酸酯的方法 |
| CA2912568A1 (en) * | 2013-05-30 | 2014-12-04 | Plexxikon Inc. | Compounds for kinase modulation, and indications therefor |
| US20160199372A1 (en) | 2013-08-20 | 2016-07-14 | Bristol-Myers Squibb Company | Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia |
| EP3265454B1 (en) | 2015-03-02 | 2020-02-26 | Rigel Pharmaceuticals, Inc. | Tgf-beta inhibitors |
-
2016
- 2016-02-26 EP EP16710547.7A patent/EP3265454B1/en active Active
- 2016-02-26 JP JP2017546173A patent/JP6836998B2/ja not_active Expired - Fee Related
- 2016-02-26 SG SG11201705821XA patent/SG11201705821XA/en unknown
- 2016-02-26 BR BR112017017135-0A patent/BR112017017135A2/pt not_active Application Discontinuation
- 2016-02-26 CN CN201680013639.0A patent/CN107406412B/zh not_active Expired - Fee Related
- 2016-02-26 EA EA201791955A patent/EA037112B1/ru unknown
- 2016-02-26 MX MX2017010735A patent/MX371167B/es active IP Right Grant
- 2016-02-26 AU AU2016226468A patent/AU2016226468B2/en not_active Ceased
- 2016-02-26 US US15/054,895 patent/US9884868B2/en active Active
- 2016-02-26 CA CA2973602A patent/CA2973602A1/en active Pending
- 2016-02-26 KR KR1020177027381A patent/KR20170122799A/ko not_active Ceased
- 2016-02-26 TN TNP/2017/000374A patent/TN2017000374A1/en unknown
- 2016-02-26 ES ES16710547T patent/ES2789331T3/es active Active
- 2016-02-26 PE PE2017001481A patent/PE20171789A1/es unknown
- 2016-02-26 WO PCT/US2016/019830 patent/WO2016140884A1/en not_active Ceased
- 2016-02-26 MY MYPI2017703205A patent/MY186133A/en unknown
- 2016-03-01 TW TW105106227A patent/TW201639827A/zh unknown
- 2016-03-02 AR ARP160100546A patent/AR103828A1/es unknown
-
2017
- 2017-07-21 PH PH12017501326A patent/PH12017501326A1/en unknown
- 2017-08-15 ZA ZA2017/05527A patent/ZA201705527B/en unknown
- 2017-08-28 IL IL254187A patent/IL254187A0/en unknown
- 2017-08-31 CL CL2017002207A patent/CL2017002207A1/es unknown
- 2017-09-27 CO CONC2017/0009891A patent/CO2017009891A2/es unknown
-
2018
- 2018-01-02 US US15/860,379 patent/US10287295B2/en active Active
-
2019
- 2019-03-21 US US16/360,162 patent/US11352360B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11845745B2 (en) | 2017-03-23 | 2023-12-19 | Clavius Pharmaceuticals, LLC. | Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018510857A5 (enExample) | ||
| JP2018501209A5 (enExample) | ||
| JP2019504821A5 (enExample) | ||
| CN104755478B (zh) | 丝氨酸/苏氨酸激酶抑制剂 | |
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| JP4974437B2 (ja) | ファルネシルトランスフェラーゼを阻害する6−[(置換フェニル)メチル]−キノリンおよびキナゾリン誘導体 | |
| TW201701879A (zh) | Irak4抑制劑組合 | |
| JP2017520607A5 (enExample) | ||
| JP2010514689A5 (enExample) | ||
| JP2023538060A (ja) | 二環化合物、それを含む組成物、及びそれらの使用 | |
| TW201840549A (zh) | 2-雜芳基-3-氧代-2,3-二氫噠嗪-4-甲醯胺 | |
| CN108430993A (zh) | Tank-结合激酶抑制剂化合物 | |
| EA037112B1 (ru) | Ингибиторы tgf- | |
| WO2015002754A2 (en) | Novel bicyclic bromodomain inhibitors | |
| JP2011503166A5 (enExample) | ||
| CN108137590A (zh) | 作为mdm2-p53抑制剂的新的螺(3h-吲哚-3,2′-吡咯烷)-2(1h)-酮化合物及其衍生物 | |
| JPWO2020231806A5 (enExample) | ||
| JP2019503385A5 (enExample) | ||
| CA3071760A1 (en) | Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors | |
| CN105980387A (zh) | 丝氨酸/苏氨酸激酶抑制剂 | |
| CN112204027A (zh) | Erk 抑制剂及其应用 | |
| JP2017532360A5 (enExample) | ||
| EP3209665A1 (en) | Heteroaryl substituted pyrrolotriazine amine compounds as pi3k inhibitors | |
| EP3713931A1 (en) | 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides | |
| EP4237086A1 (en) | Heterocyclic spiro compounds and methods of use |